(+)-pilocarpine multiple interactions ISO RGD:2843 6480464 [Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 mRNA more ... CTD PMID:21429313 (+)-schisandrin B multiple interactions ISO RGD:2843 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 mRNA] CTD PMID:31150632 (+)-Tetrandrine increases expression EXP 6480464 tetrandrine results in increased expression of HSPA5 protein CTD PMID:26822499 (-)-anisomycin decreases expression ISO RGD:10742 6480464 Anisomycin results in decreased expression of HSPA5 mRNA, Anisomycin results in decreased expression of HSPA5 protein CTD PMID:25324550 (-)-gambogic acid increases expression EXP 6480464 gambogic acid results in increased expression of HSPA5 protein CTD PMID:24291039 (-)-gambogic acid multiple interactions EXP 6480464 Bortezomib promotes the reaction [gambogic acid results in increased expression of HSPA5 protein], gambogic acid promotes the reaction [Bortezomib results in increased expression of HSPA5 protein] CTD PMID:24291039 (R)-adrenaline multiple interactions ISO RGD:2843 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of HSPA5 protein CTD PMID:19464573 (R)-lipoic acid multiple interactions ISO RGD:10742 6480464 Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of HSPA5 protein] CTD PMID:23892647 (R)-lipoic acid multiple interactions ISO RGD:2843 6480464 Thioctic Acid inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] CTD PMID:30605698 (R)-noradrenaline increases expression ISO RGD:2843 6480464 Norepinephrine results in increased expression of HSPA5 mRNA, Norepinephrine results in increased expression of HSPA5 protein CTD PMID:16338971 (R,S)-Scoulerine multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [discretamine results in increased expression of HSPA5 protein], Acetylcysteine inhibits the reaction [discretamine results in increased expression of HSPA5 protein] CTD PMID:32590070 (R,S)-Scoulerine increases expression EXP 6480464 discretamine results in increased expression of HSPA5 protein CTD PMID:32590070 (S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of HSPA5 protein CTD PMID:27358234 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of HSPA5 CTD PMID:24201001 (S)-nicotine multiple interactions ISO RGD:10742 6480464 Nicotine inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28082123 (S)-nicotine multiple interactions ISO RGD:2843 6480464 Nicotine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein], Nicotine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] CTD PMID:18477628 , PMID:28082123 (Z)-3-butylidenephthalide increases expression EXP 6480464 butylidenephthalide results in increased expression of HSPA5 protein CTD PMID:23770345 1,2-dichloroethane increases expression ISO RGD:10742 6480464 ethylene dichloride results in increased expression of HSPA5 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:2843 6480464 p-coumaric acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of HSPA5 protein] CTD PMID:29879413 1,2-dimethylhydrazine multiple interactions ISO RGD:10742 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of HSPA5 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:10742 6480464 1, 2-Dimethylhydrazine results in increased expression of HSPA5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:2843 6480464 1, 2-Dimethylhydrazine results in increased expression of HSPA5 protein CTD PMID:29879413 1,3-dinitrobenzene increases metabolic processing ISO RGD:2843 6480464 3-dinitrobenzene results in increased metabolism of HSPA5 protein CTD PMID:21402099 1,4-dithiothreitol increases expression EXP 6480464 Dithiothreitol metabolite results in increased expression of HSPA5 protein more ... CTD PMID:15710169 more ... 1,4-dithiothreitol increases expression ISO RGD:2843 6480464 Dithiothreitol metabolite results in increased expression of HSPA5 protein CTD PMID:17416481 1-bromopropane increases expression ISO RGD:2843 6480464 1-bromopropane results in increased expression of HSPA5 protein CTD PMID:21925529 1-bromopropane increases expression ISO RGD:10742 6480464 1-bromopropane results in increased expression of HSPA5 protein CTD PMID:27421776 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:10742 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:24140863 , PMID:28082123 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:10742 6480464 Nicotine inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28082123 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 TXN protein inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:24140863 1-nitropyrene multiple interactions EXP 6480464 Dicumarol inhibits the reaction [1-nitropyrene results in increased expression of HSPA5 protein] CTD PMID:19460413 1-nitropyrene increases expression EXP 6480464 1-nitropyrene results in increased expression of HSPA5 protein CTD PMID:19460413 15-acetyldeoxynivalenol decreases expression EXP 6480464 15-acetyldeoxynivalenol results in decreased expression of HSPA5 mRNA CTD PMID:20682335 17alpha-ethynylestradiol affects expression ISO RGD:10742 6480464 Ethinyl Estradiol affects the expression of HSPA5 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:10742 6480464 Ethinyl Estradiol results in increased expression of HSPA5 mRNA CTD PMID:16174780 more ... 17alpha-ethynylestradiol increases expression ISO RGD:2843 6480464 Ethinyl Estradiol results in increased expression of HSPA5 mRNA CTD PMID:16174780 , PMID:19400957 17alpha-ethynylestradiol affects expression ISO RGD:2843 6480464 Ethinyl Estradiol affects the expression of HSPA5 mRNA CTD PMID:20170705 17alpha-ethynylestradiol multiple interactions ISO RGD:10742 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA5 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with ESR1 protein] results in increased expression of HSPA5 protein more ... CTD PMID:19269315 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of HSPA5 mRNA CTD PMID:23094148 17beta-estradiol increases expression ISO RGD:10742 6480464 Estradiol results in increased expression of HSPA5 mRNA, Estradiol results in increased expression of HSPA5 protein CTD PMID:14664709 , PMID:17640991 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one affects localization EXP 6480464 Metribolone affects the localization of HSPA5 protein CTD PMID:17440980 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression EXP 6480464 Metribolone results in increased expression of HSPA5 protein CTD PMID:17152098 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions EXP 6480464 Metribolone promotes the reaction [NDRG1 protein binds to HSPA5 protein] CTD PMID:17220478 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of HSPA5 mRNA CTD PMID:29581250 1H-pyrazole multiple interactions ISO RGD:10742 6480464 G6PDX affects the reaction [pyrazole results in increased expression of HSPA5 protein], Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein] CTD PMID:18068688 1H-pyrazole increases expression ISO RGD:10742 6480464 pyrazole results in increased expression of HSPA5 mRNA, pyrazole results in increased expression of HSPA5 protein CTD PMID:12499123 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19095052 , PMID:22543052 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:10742 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:2843 6480464 2 more ... CTD PMID:30029115 2,2,2-tetramine multiple interactions ISO RGD:2843 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of HSPA5 protein] CTD PMID:19634143 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid decreases expression EXP 6480464 2 more ... CTD PMID:32790152 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA5 mRNA CTD PMID:16039398 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2843 6480464 EIF2S1 mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein], salubrinal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein] CTD PMID:24932542 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2843 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA5 protein CTD PMID:12361703 , PMID:24932542 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10742 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2843 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2843 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA5 mRNA, Tetrachlorodibenzodioxin results in decreased expression of HSPA5 protein CTD PMID:16548065 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10742 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA5 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10742 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA5 mRNA CTD PMID:17942748 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:2843 6480464 Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein] CTD PMID:30503585 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:2843 6480464 Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein CTD PMID:30503585 2,4,6-trinitrotoluene affects expression ISO RGD:2843 6480464 Trinitrotoluene affects the expression of HSPA5 mRNA CTD PMID:21346803 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:10742 6480464 2 more ... CTD PMID:18550172 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:2843 6480464 2 more ... CTD PMID:19954255 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:2843 6480464 2 more ... CTD PMID:19954255 2,4-dichlorophenol increases expression EXP 6480464 2 more ... CTD PMID:27853103 2,4-dichlorophenol increases expression ISO RGD:10742 6480464 2 more ... CTD PMID:25160872 , PMID:27853103 2,4-dichlorophenol multiple interactions ISO RGD:10742 6480464 ursodoxicoltaurine inhibits the reaction [2 more ... CTD PMID:25160872 , PMID:27853103 2,4-dinitrotoluene increases expression EXP 6480464 2, 4-dinitrotoluene results in increased expression of HSPA5 mRNA CTD PMID:11409192 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 mRNA] more ... CTD PMID:28844859 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] CTD PMID:20165829 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein] CTD PMID:30602124 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:10742 6480464 Glucosamine results in increased expression of HSPA5 mRNA, Glucosamine results in increased expression of HSPA5 protein CTD PMID:30602124 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of HSPA5 mRNA, Glucosamine results in increased expression of HSPA5 protein CTD PMID:15618547 more ... 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] CTD PMID:20165829 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:2843 6480464 Glucosamine results in increased expression of HSPA5 mRNA CTD PMID:20165829 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:10742 6480464 Glucosamine results in decreased expression of HSPA5 mRNA CTD PMID:17178593 2-arachidonoylglycerol increases expression EXP 6480464 glyceryl 2-arachidonate results in increased expression of HSPA5 mRNA CTD PMID:32357311 2-deoxy-D-glucose multiple interactions EXP 6480464 4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 mRNA] more ... CTD PMID:20593179 more ... 2-deoxy-D-glucose increases expression EXP 6480464 Deoxyglucose results in increased expression of HSPA5 mRNA, Deoxyglucose results in increased expression of HSPA5 protein CTD PMID:20593179 , PMID:31022492 2-hydroxypropanoic acid multiple interactions EXP 6480464 HSPA5 protein affects the reaction [A2M protein modified form results in increased secretion of Lactic Acid] CTD PMID:25720493 2-methyl-6-(phenylethynyl)pyridine multiple interactions ISO RGD:2843 6480464 6-methyl-2-phenylethynylpyridine inhibits the reaction [Cocaine results in increased expression of HSPA5 protein] CTD PMID:17303341 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein] CTD PMID:25341683 20-hydroxyecdysone increases expression EXP 6480464 Ecdysterone results in increased expression of HSPA5 mRNA CTD PMID:29126784 20-hydroxyecdysone decreases expression EXP 6480464 Ecdysterone results in decreased expression of HSPA5 protein CTD PMID:29126784 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression ISO RGD:2843 6480464 Puromycin Aminonucleoside results in decreased expression of HSPA5 protein CTD PMID:19264907 3,3'-diindolylmethane decreases expression EXP 6480464 3, 3'-diindolylmethane analog results in decreased expression of HSPA5 protein CTD PMID:25794856 3,3'-diindolylmethane multiple interactions EXP 6480464 3, 3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein] CTD PMID:25794856 3-acetyldeoxynivalenol decreases expression EXP 6480464 3-acetyldeoxynivalenol results in decreased expression of HSPA5 mRNA CTD PMID:20682335 3-chloropropane-1,2-diol decreases expression ISO RGD:2843 6480464 alpha-Chlorohydrin results in decreased expression of HSPA5 protein CTD PMID:26597043 3-methyladenine multiple interactions EXP 6480464 3-methyladenine promotes the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] CTD PMID:28245985 3H-1,2-dithiole-3-thione increases expression ISO RGD:10742 6480464 1, 2-dithiol-3-thione results in increased expression of HSPA5 mRNA CTD PMID:15302862 3H-1,2-dithiole-3-thione decreases expression ISO RGD:2843 6480464 1, 2-dithiol-3-thione results in decreased expression of HSPA5 mRNA CTD PMID:19162173 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions EXP 6480464 4 more ... CTD PMID:29421517 4-hydroxynon-2-enal affects binding EXP 6480464 4-hydroxy-2-nonenal analog binds to HSPA5 CTD PMID:18232660 4-hydroxynon-2-enal multiple interactions ISO RGD:2843 6480464 Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA] CTD PMID:24291486 4-hydroxynon-2-enal increases expression ISO RGD:2843 6480464 4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA, 4-hydroxy-2-nonenal results in increased expression of HSPA5 protein CTD PMID:24291486 4-hydroxyphenyl retinamide multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased expression of HSPA5 protein] CTD PMID:17353921 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of HSPA5 protein CTD PMID:17353921 , PMID:20546536 4-hydroxyphenyl retinamide decreases expression ISO RGD:10742 6480464 Fenretinide results in decreased expression of HSPA5 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases response to substance EXP 6480464 HSPA5 results in decreased susceptibility to Fenretinide CTD PMID:20546536 4-phenylbutylamine multiple interactions ISO RGD:10742 6480464 4-phenylbutylamine promotes the reaction [Zearalenone results in increased expression of HSPA5 protein] CTD PMID:30394307 4-phenylbutyric acid multiple interactions ISO RGD:10742 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2 more ... CTD PMID:17459145 more ... 4-phenylbutyric acid decreases expression ISO RGD:10742 6480464 4-phenylbutyric acid results in decreased expression of HSPA5 protein CTD PMID:28698385 4-phenylbutyric acid decreases expression ISO RGD:2843 6480464 4-phenylbutyric acid results in decreased expression of HSPA5 protein CTD PMID:27484784 , PMID:28844859 4-phenylbutyric acid multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 mRNA] more ... CTD PMID:20165829 more ... 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [discretamine results in increased expression of HSPA5 protein] more ... CTD PMID:20165829 more ... 5-(N,N-hexamethylene)amiloride affects expression EXP 6480464 5-N, N-hexamethyleneamiloride affects the expression of HSPA5 mRNA CTD PMID:19302589 5-fluorouracil decreases expression EXP 6480464 Fluorouracil results in decreased expression of HSPA5 protein CTD PMID:29879413 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:2843 6480464 6-chloro-2 more ... CTD PMID:31433112 7,12-dimethyltetraphene multiple interactions ISO RGD:2843 6480464 [9 more ... CTD PMID:22248470 7,12-dimethyltetraphene increases expression ISO RGD:2843 6480464 9 more ... CTD PMID:22248470 7H-xanthine multiple interactions ISO RGD:2843 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of HSPA5 protein CTD PMID:19464573 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSPA5 mRNA CTD PMID:22079614 9H-xanthine multiple interactions ISO RGD:2843 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in increased expression of HSPA5 protein CTD PMID:19464573 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of HSPA5 mRNA CTD PMID:14976132 acrolein increases expression EXP 6480464 Acrolein results in increased expression of HSPA5 protein CTD PMID:18951912 acrolein multiple interactions ISO RGD:2843 6480464 3 more ... CTD PMID:29414845 acrolein increases expression ISO RGD:2843 6480464 Acrolein results in increased expression of HSPA5 mRNA, Acrolein results in increased expression of HSPA5 protein CTD PMID:28119953 , PMID:29414845 acrolein decreases expression ISO RGD:10742 6480464 Acrolein results in decreased expression of HSPA5 mRNA CTD PMID:28482051 acrylamide increases expression ISO RGD:2843 6480464 Acrylamide results in increased expression of HSPA5 protein CTD PMID:33421551 actinomycin D multiple interactions ISO RGD:2843 6480464 Dactinomycin inhibits the reaction [Benzoapyrene results in increased expression of HSPA5 mRNA] more ... CTD PMID:17915553 aflatoxin B1 decreases expression ISO RGD:10742 6480464 Aflatoxin B1 results in decreased expression of HSPA5 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of HSPA5 mRNA CTD PMID:27153756 aldehydo-D-glucosamine multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] CTD PMID:20165829 aldehydo-D-glucosamine increases expression ISO RGD:10742 6480464 Glucosamine results in increased expression of HSPA5 mRNA, Glucosamine results in increased expression of HSPA5 protein CTD PMID:30602124 aldehydo-D-glucosamine multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein] CTD PMID:30602124 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of HSPA5 mRNA, Glucosamine results in increased expression of HSPA5 protein CTD PMID:15618547 more ... aldehydo-D-glucosamine multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] CTD PMID:20165829 aldehydo-D-glucosamine increases expression ISO RGD:2843 6480464 Glucosamine results in increased expression of HSPA5 mRNA CTD PMID:20165829 aldehydo-D-glucosamine decreases expression ISO RGD:10742 6480464 Glucosamine results in decreased expression of HSPA5 mRNA CTD PMID:17178593 aldehydo-D-glucose increases expression EXP 6480464 Glucose deficiency results in increased expression of HSPA5 mRNA more ... CTD PMID:12147617 more ... aldehydo-D-glucose increases expression ISO RGD:10742 6480464 Glucose results in increased expression of HSPA5 mRNA, Glucose results in increased expression of HSPA5 protein CTD PMID:30076216 aldehydo-D-glucose multiple interactions ISO RGD:10742 6480464 2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein] more ... CTD PMID:21705745 , PMID:30076216 aldehydo-D-glucose multiple interactions EXP 6480464 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA] more ... CTD PMID:25451566 , PMID:31022492 aldehydo-D-glucose decreases expression ISO RGD:2843 6480464 Glucose results in decreased expression of HSPA5 mRNA CTD PMID:24349266 aldehydo-D-glucose increases expression ISO RGD:2843 6480464 Glucose deficiency results in increased expression of HSPA5 protein CTD PMID:21337367 aldehydo-D-glucose decreases expression ISO RGD:10742 6480464 Glucose results in decreased expression of HSPA5 mRNA CTD PMID:17178593 all-trans-retinal increases expression EXP 6480464 Retinaldehyde results in increased expression of HSPA5 protein CTD PMID:25331497 all-trans-retinoic acid multiple interactions EXP 6480464 MGAT5 protein inhibits the reaction [Tretinoin results in increased expression of HSPA5 protein] CTD PMID:17031849 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of HSPA5 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:10742 6480464 Tretinoin results in increased expression of HSPA5 mRNA, Tretinoin results in increased expression of HSPA5 protein CTD PMID:22498432 all-trans-retinoic acid increases expression ISO RGD:2843 6480464 Tretinoin results in increased expression of HSPA5 mRNA CTD PMID:20488242 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of HSPA5 protein CTD PMID:17031849 , PMID:19960509 alloxan increases expression ISO RGD:10742 6480464 Alloxan results in increased expression of HSPA5 mRNA CTD PMID:30076216 Aloe emodin increases expression EXP 6480464 aloe emodin results in increased expression of HSPA5 mRNA, aloe emodin results in increased expression of HSPA5 protein CTD PMID:22210228 alpha-(methylamino)isobutyric acid multiple interactions ISO RGD:10742 6480464 2-methylaminoisobutyric acid inhibits the reaction [arsenite results in increased expression of HSPA5 mRNA] CTD PMID:22215663 alpha-D-galactose multiple interactions EXP 6480464 Phycocyanin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] CTD PMID:23036742 alpha-D-galactose increases expression EXP 6480464 Galactose results in increased expression of HSPA5 protein CTD PMID:23036742 amiloride multiple interactions ISO RGD:10742 6480464 Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA], Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] CTD PMID:20015086 ammonium chloride affects expression ISO RGD:2843 6480464 Ammonium Chloride affects the expression of HSPA5 mRNA CTD PMID:16483693 amosite asbestos increases expression EXP 6480464 Asbestos more ... CTD PMID:23885834 amphibole asbestos decreases expression EXP 6480464 Asbestos, Amphibole results in decreased expression of HSPA5 protein CTD PMID:20855422 aniline increases nitrosation ISO RGD:2843 6480464 aniline results in increased nitrosation of HSPA5 protein CTD PMID:21708182 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Indomethacin results in increased expression of HSPA5 protein] CTD PMID:17341418 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:2843 6480464 pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA] CTD PMID:20920558 antimycin A increases expression ISO RGD:2843 6480464 Antimycin A results in increased expression of HSPA5 protein CTD PMID:21337367 apigenin multiple interactions ISO RGD:10742 6480464 Apigenin inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein], Apigenin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] CTD PMID:20493918 apigenin decreases expression ISO RGD:10742 6480464 Apigenin results in decreased expression of HSPA5 mRNA CTD PMID:22359648 aristolochic acid increases expression EXP 6480464 aristolochic acid I results in increased expression of HSPA5 CTD PMID:22445861 aristolochic acid decreases expression EXP 6480464 aristolochic acid I results in decreased expression of HSPA5 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:10742 6480464 Chlorodiphenyl 54% Chlorine results in decreased expression of HSPA5 mRNA CTD PMID:23650126 arsane decreases expression ISO RGD:10742 6480464 Arsenic results in decreased expression of HSPA5 protein CTD PMID:22552367 arsane increases expression EXP 6480464 Arsenic results in increased expression of HSPA5 protein CTD PMID:19818359 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of HSPA5 protein CTD PMID:19818359 arsenic atom decreases expression ISO RGD:10742 6480464 Arsenic results in decreased expression of HSPA5 protein CTD PMID:22552367 arsenite(3-) multiple interactions ISO RGD:10742 6480464 2-methylaminoisobutyric acid inhibits the reaction [arsenite results in increased expression of HSPA5 mRNA], TRP53 protein affects the reaction [arsenite results in decreased expression of HSPA5 mRNA] CTD PMID:18929588 , PMID:22215663 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of HSPA5 protein CTD PMID:22959463 , PMID:26677073 arsenite(3-) increases expression ISO RGD:10742 6480464 arsenite results in increased expression of HSPA5 mRNA CTD PMID:22215663 arsenite(3-) decreases expression ISO RGD:10742 6480464 arsenite results in decreased expression of HSPA5 mRNA CTD PMID:18929588 arsenous acid increases expression ISO RGD:2843 6480464 Arsenic Trioxide results in increased expression of HSPA5 protein CTD PMID:21145380 arsenous acid increases expression ISO RGD:10742 6480464 Arsenic Trioxide results in increased expression of HSPA5 mRNA, Arsenic Trioxide results in increased expression of HSPA5 protein CTD PMID:21533816 more ... arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of HSPA5 mRNA, Arsenic Trioxide results in increased expression of HSPA5 protein CTD PMID:11678611 more ... arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of HSPA5 mRNA CTD PMID:24356939 , PMID:25424538 arsenous acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]] more ... CTD PMID:11678611 more ... arsenous acid affects response to substance EXP 6480464 HSPA5 protein affects the susceptibility to Arsenic Trioxide CTD PMID:19695276 arsenous acid multiple interactions ISO RGD:10742 6480464 1 more ... CTD PMID:21533816 more ... arsenous acid multiple interactions ISO RGD:2843 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein] CTD PMID:21145380 atazanavir sulfate decreases expression EXP 6480464 Atazanavir Sulfate results in decreased expression of HSPA5 mRNA CTD PMID:32152650 atazanavir sulfate multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA CTD PMID:32152650 ATP multiple interactions EXP 6480464 [Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of HSPA5 mRNA more ... CTD PMID:24149798 atrazine multiple interactions EXP 6480464 Atrazine promotes the reaction [arsenic trioxide results in increased expression of HSPA5 mRNA] CTD PMID:11678611 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of HSPA5 mRNA CTD PMID:22378314 BAPTA multiple interactions EXP 6480464 1 more ... CTD PMID:28181380 beauvericin multiple interactions EXP 6480464 [beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA CTD PMID:31100301 benomyl increases expression EXP 6480464 Benomyl results in increased expression of HSPA5 protein CTD PMID:27784618 benomyl multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Benomyl results in increased expression of HSPA5 protein], MitoTEMPO inhibits the reaction [Benomyl results in increased expression of HSPA5 protein] CTD PMID:27784618 benzalkonium chloride decreases expression EXP 6480464 Benzalkonium Compounds results in decreased expression of HSPA5 mRNA CTD PMID:28236482 benzene increases expression EXP 6480464 Benzene results in increased expression of HSPA5 protein CTD PMID:12183065 benzo[a]pyrene increases expression ISO RGD:10742 6480464 Benzoapyrene results in increased expression of HSPA5 mRNA, Benzoapyrene results in increased expression of HSPA5 protein CTD PMID:17915553 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of HSPA5 mRNA CTD PMID:21632981 , PMID:26238291 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene metabolite results in increased expression of HSPA5 mRNA CTD PMID:24356939 benzo[a]pyrene decreases expression ISO RGD:10742 6480464 Benzoapyrene results in decreased expression of HSPA5 mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene multiple interactions ISO RGD:2843 6480464 Dactinomycin inhibits the reaction [Benzoapyrene results in increased expression of HSPA5 mRNA] CTD PMID:17915553 benzo[a]pyrene increases expression ISO RGD:2843 6480464 Benzoapyrene results in increased expression of HSPA5 mRNA CTD PMID:17915553 beta-D-glucosamine multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] CTD PMID:20165829 beta-D-glucosamine multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein] CTD PMID:30602124 beta-D-glucosamine increases expression ISO RGD:10742 6480464 Glucosamine results in increased expression of HSPA5 mRNA, Glucosamine results in increased expression of HSPA5 protein CTD PMID:30602124 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of HSPA5 mRNA, Glucosamine results in increased expression of HSPA5 protein CTD PMID:15618547 more ... beta-D-glucosamine multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] CTD PMID:20165829 beta-D-glucosamine increases expression ISO RGD:2843 6480464 Glucosamine results in increased expression of HSPA5 mRNA CTD PMID:20165829 beta-D-glucosamine decreases expression ISO RGD:10742 6480464 Glucosamine results in decreased expression of HSPA5 mRNA CTD PMID:17178593 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of HSPA5 mRNA CTD PMID:19737606 bifenthrin increases expression EXP 6480464 bifenthrin results in increased expression of HSPA5 protein CTD PMID:16271832 bilirubin IXalpha increases expression EXP 6480464 Bilirubin results in increased expression of HSPA5 mRNA, Bilirubin results in increased expression of HSPA5 protein CTD PMID:20196124 , PMID:27578021 bilirubin IXalpha multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of HSPA5 mRNA], Bilirubin inhibits the reaction [[Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA] CTD PMID:27578021 , PMID:32033040 bis(2-chloroethyl) sulfide increases expression ISO RGD:10742 6480464 Mustard Gas results in increased expression of HSPA5 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:2843 6480464 Diethylhexyl Phthalate results in decreased expression of HSPA5 protein CTD PMID:16400681 bis(2-ethylhexyl) phthalate increases expression ISO RGD:2843 6480464 Diethylhexyl Phthalate results in increased expression of HSPA5 mRNA CTD PMID:21318169 , PMID:25280772 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10742 6480464 Diethylhexyl Phthalate results in decreased expression of HSPA5 mRNA CTD PMID:21318169 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HSPA5 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A affects expression ISO RGD:2843 6480464 bisphenol A affects the expression of HSPA5 mRNA CTD PMID:30903817 bisphenol A increases methylation ISO RGD:2843 6480464 bisphenol A results in increased methylation of HSPA5 gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:2843 6480464 bisphenol A results in decreased expression of HSPA5 mRNA CTD PMID:30816183 , PMID:33296240 bisphenol A decreases expression ISO RGD:10742 6480464 bisphenol A results in decreased expression of HSPA5 protein CTD PMID:21705745 bisphenol A multiple interactions ISO RGD:10742 6480464 Glucose affects the reaction [bisphenol A results in decreased expression of HSPA5 protein] CTD PMID:21705745 bisphenol A increases expression ISO RGD:2843 6480464 bisphenol A results in increased expression of HSPA5 mRNA, bisphenol A results in increased expression of HSPA5 protein CTD PMID:22649256 , PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HSPA5 mRNA CTD PMID:25333893 , PMID:25619500 bisphenol A increases expression ISO RGD:10742 6480464 bisphenol A results in increased expression of HSPA5 mRNA, bisphenol A results in increased expression of HSPA5 protein CTD PMID:12233820 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with ESR1 protein] results in increased expression of HSPA5 protein CTD PMID:19269315 bleomycin A2 increases expression ISO RGD:2843 6480464 Bleomycin results in increased expression of HSPA5 protein CTD PMID:25933445 boric acid increases expression EXP 6480464 boric acid results in increased expression of HSPA5 mRNA, boric acid results in increased expression of HSPA5 protein CTD PMID:25425213 , PMID:27587023 bortezomib multiple interactions EXP 6480464 Bortezomib inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein] more ... CTD PMID:15141013 more ... bortezomib increases expression ISO RGD:10742 6480464 Bortezomib results in increased expression of HSPA5 mRNA CTD PMID:15509775 bortezomib decreases response to substance EXP 6480464 HSPA5 results in decreased susceptibility to Bortezomib CTD PMID:20546536 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of HSPA5 more ... CTD PMID:15141013 more ... brefeldin A multiple interactions ISO RGD:10742 6480464 Acetylcysteine inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein] more ... CTD PMID:20493918 brefeldin A increases expression EXP 6480464 Brefeldin A results in increased expression of HSPA5 mRNA, Brefeldin A results in increased expression of HSPA5 protein CTD PMID:12147617 more ... brefeldin A increases expression ISO RGD:10742 6480464 Brefeldin A results in increased expression of HSPA5 protein CTD PMID:20493918 brefeldin A multiple interactions EXP 6480464 Bortezomib inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein], Brefeldin A inhibits the reaction [Shiga toxin subunit A results in increased cleavage of HSPA5 protein] CTD PMID:18723477 , PMID:33483759 bromobenzene decreases expression ISO RGD:2843 6480464 bromobenzene results in decreased expression of HSPA5 mRNA CTD PMID:15056800 bromobenzene affects binding ISO RGD:2843 6480464 bromobenzene metabolite binds to HSPA5 protein CTD PMID:12018992 bromobenzene increases expression ISO RGD:2843 6480464 bromobenzene results in increased expression of HSPA5 mRNA CTD PMID:12628495 bufalin decreases expression EXP 6480464 bufalin results in decreased expression of HSPA5 mRNA CTD PMID:27444971 bupropion increases expression EXP 6480464 Bupropion results in increased expression of HSPA5 protein CTD PMID:21354251 buspirone decreases expression ISO RGD:2843 6480464 Buspirone results in decreased expression of HSPA5 mRNA CTD PMID:24136188 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of HSPA5 protein CTD PMID:29319206 butyric acid multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein], Plicamycin inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein] CTD PMID:26784903 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of HSPA5 protein CTD PMID:26784903 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of HSPA5 mRNA, Cadmium results in increased expression of HSPA5 protein CTD PMID:16020198 more ... cadmium dichloride increases expression ISO RGD:10742 6480464 Cadmium Chloride results in increased expression of HSPA5 mRNA, Cadmium Chloride results in increased expression of HSPA5 protein CTD PMID:15081267 more ... cadmium dichloride multiple interactions ISO RGD:2843 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]] more ... CTD PMID:31433112 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of HSPA5 protein CTD PMID:24419708 , PMID:26220685 cadmium dichloride multiple interactions EXP 6480464 FBXO6 protein inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein] CTD PMID:25374377 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of HSPA5 mRNA CTD PMID:23828170 cadmium dichloride multiple interactions ISO RGD:10742 6480464 LL Z1640-2 inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA] CTD PMID:15081267 cadmium dichloride increases expression ISO RGD:2843 6480464 Cadmium Chloride results in increased expression of HSPA5 mRNA, Cadmium Chloride results in increased expression of HSPA5 protein CTD PMID:18636176 more ... cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of HSPA5 mRNA, Cadmium Chloride results in increased expression of HSPA5 protein CTD PMID:18560533 more ... cadmium sulfate increases expression EXP 6480464 cadmium sulfate results in increased expression of HSPA5 mRNA CTD PMID:12064557 Calcimycin increases expression EXP 6480464 Calcimycin results in increased expression of HSPA5 mRNA, Calcimycin results in increased expression of HSPA5 protein CTD PMID:12147617 more ... Calcimycin increases expression ISO RGD:10742 6480464 Calcimycin results in increased expression of HSPA5 mRNA, Calcimycin results in increased expression of HSPA5 protein CTD PMID:14610226 , PMID:18799549 Calcimycin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 mRNA], Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 protein] CTD PMID:19428936 calcium atom multiple interactions EXP 6480464 [DNAJB11 protein binds to HSPA5 protein] which results in decreased transport of Calcium more ... CTD PMID:26085089 calcium atom decreases transport EXP 6480464 HSPA5 protein results in decreased transport of Calcium CTD PMID:26085089 calcium(0) multiple interactions EXP 6480464 [DNAJB11 protein binds to HSPA5 protein] which results in decreased transport of Calcium more ... CTD PMID:26085089 calcium(0) decreases transport EXP 6480464 HSPA5 protein results in decreased transport of Calcium CTD PMID:26085089 calix[6]arene increases expression EXP 6480464 calix6arene results in increased expression of HSPA5 protein CTD PMID:23872419 Candesartan cilexetil decreases expression ISO RGD:2843 6480464 candesartan cilexetil results in decreased expression of HSPA5 protein CTD PMID:22120037 cannabidiol multiple interactions ISO RGD:10742 6480464 [Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA, Bilirubin inhibits the reaction [[Cannabidiol co-treated with Rotenone] results in increased expression of HSPA5 mRNA] CTD PMID:32033040 cantharidin increases expression EXP 6480464 Cantharidin results in increased expression of HSPA5 protein CTD PMID:27113412 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of HSPA5, Capsaicin results in increased expression of HSPA5 protein CTD PMID:19139269 more ... capsaicin increases localization EXP 6480464 Capsaicin results in increased localization of HSPA5 protein CTD PMID:19331147 carbaryl increases expression EXP 6480464 Carbaryl results in increased expression of HSPA5 mRNA CTD PMID:11226373 , PMID:27829164 carbon atom multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased expression of HSPA5 mRNA, [Air Pollutants results in increased abundance of Carbon] which results in increased expression of HSPA5 mRNA CTD PMID:31268311 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:22157353 , PMID:30138652 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of HSPA5 mRNA CTD PMID:30802478 carbon nanotube increases expression ISO RGD:10742 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carboplatin decreases expression ISO RGD:2843 6480464 Carboplatin results in decreased expression of HSPA5 mRNA CTD PMID:18172885 casticin increases expression EXP 6480464 casticin results in increased expression of HSPA5 protein CTD PMID:27862857 celastrol increases expression EXP 6480464 celastrol results in increased expression of HSPA5 mRNA CTD PMID:17010675 celecoxib increases expression EXP 6480464 Celecoxib results in increased expression of HSPA5 CTD PMID:21567098 ceruletide decreases expression ISO RGD:2843 6480464 Ceruletide results in decreased expression of HSPA5 protein CTD PMID:18024178 chenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... CTD PMID:32152650 Chikusetsusaponin-V multiple interactions EXP 6480464 chikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] CTD PMID:25073091 chlordecone multiple interactions ISO RGD:10742 6480464 [Chlordecone co-treated with fulvestrant] results in increased expression of HSPA5 protein more ... CTD PMID:17640991 chlordecone increases response to substance ISO RGD:10742 6480464 HSPA5 protein results in increased susceptibility to Chlordecone CTD PMID:17640991 chlordecone increases expression ISO RGD:10742 6480464 Chlordecone results in increased expression of HSPA5 mRNA, Chlordecone results in increased expression of HSPA5 protein CTD PMID:17640991 chlorhexidine increases expression ISO RGD:10742 6480464 Chlorhexidine results in increased expression of HSPA5 protein CTD PMID:19027770 chloroacetaldehyde decreases expression EXP 6480464 chloroacetaldehyde results in decreased expression of HSPA5 mRNA CTD PMID:25596134 chloroacetic acid increases expression ISO RGD:10742 6480464 chloroacetic acid results in increased expression of HSPA5 mRNA, chloroacetic acid results in increased expression of HSPA5 protein CTD PMID:25451595 chloroacetic acid multiple interactions ISO RGD:10742 6480464 Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of HSPA5 protein] more ... CTD PMID:25451595 chlorobenzene increases expression EXP 6480464 chlorobenzene results in increased expression of HSPA5 protein CTD PMID:12183065 chloroethene increases expression ISO RGD:10742 6480464 Vinyl Chloride results in increased expression of HSPA5 mRNA CTD PMID:31445928 chloropicrin increases expression EXP 6480464 chloropicrin results in increased expression of HSPA5 protein CTD PMID:22516760 chloroquine multiple interactions ISO RGD:2843 6480464 Chloroquine promotes the reaction [cadmium acetate results in increased expression of HSPA5 protein] CTD PMID:29870746 chlorpyrifos increases expression ISO RGD:10742 6480464 Chlorpyrifos results in increased expression of HSPA5 mRNA CTD PMID:22515965 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of HSPA5 protein CTD PMID:27993609 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of HSPA5 mRNA CTD PMID:25424538 choline affects expression EXP 6480464 Choline affects the expression of HSPA5 mRNA CTD PMID:17616785 choline multiple interactions ISO RGD:10742 6480464 [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HSPA5 protein more ... CTD PMID:20938992 more ... chromium(6+) multiple interactions ISO RGD:2843 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of HSPA5 protein CTD PMID:30974164 chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of HSPA5 protein CTD PMID:30416085 chrysazin increases expression EXP 6480464 danthron results in increased expression of HSPA5 protein CTD PMID:21126053 cidofovir anhydrous decreases expression EXP 6480464 Cidofovir results in decreased expression of HSPA5 mRNA CTD PMID:25596134 cimetidine multiple interactions ISO RGD:10742 6480464 Cimetidine inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] CTD PMID:27983966 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of HSPA5 mRNA more ... CTD PMID:25611565 more ... cisplatin multiple interactions ISO RGD:10742 6480464 Linagliptin inhibits the reaction [Cisplatin results in increased expression of HSPA5 mRNA] CTD PMID:32567747 cisplatin increases expression ISO RGD:10742 6480464 Cisplatin results in increased expression of HSPA5 mRNA CTD PMID:32567747 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of HSPA5 mRNA CTD PMID:11099651 more ... cisplatin increases expression ISO RGD:2843 6480464 Cisplatin results in increased expression of HSPA5 mRNA, Cisplatin results in increased expression of HSPA5 protein CTD PMID:23603837 cisplatin multiple interactions ISO RGD:2843 6480464 Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of HSPA5 mRNA], Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of HSPA5 protein] CTD PMID:23603837 cisplatin affects expression ISO RGD:2843 6480464 Cisplatin affects the expression of HSPA5 protein CTD PMID:20071420 cisplatin decreases expression ISO RGD:10742 6480464 Cisplatin results in decreased expression of HSPA5 mRNA CTD PMID:21151649 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of HSPA5 mRNA, Cisplatin results in increased expression of HSPA5 protein CTD PMID:16357177 , PMID:19561079 clofibrate decreases expression ISO RGD:10742 6480464 Clofibrate results in decreased expression of HSPA5 mRNA CTD PMID:17585979 clofibrate decreases expression ISO RGD:2843 6480464 Clofibrate results in decreased expression of HSPA5 mRNA CTD PMID:21318169 cobalt dichloride increases expression ISO RGD:2843 6480464 cobaltous chloride results in increased expression of HSPA5 protein CTD PMID:21337367 cobicistat multiple interactions ISO RGD:10742 6480464 [1 more ... CTD PMID:33629115 cocaine increases expression EXP 6480464 Cocaine results in increased expression of HSPA5 mRNA CTD PMID:15009677 cocaine increases expression ISO RGD:2843 6480464 Cocaine results in increased expression of HSPA5 mRNA, Cocaine results in increased expression of HSPA5 protein CTD PMID:17303341 , PMID:23644055 cocaine multiple interactions ISO RGD:2843 6480464 6-methyl-2-phenylethynylpyridine inhibits the reaction [Cocaine results in increased expression of HSPA5 protein] more ... CTD PMID:17303341 colforsin daropate hydrochloride increases response to substance EXP 6480464 HSPA5 protein results in increased susceptibility to Colforsin CTD PMID:22912664 copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of HSPA5 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of HSPA5 protein CTD PMID:15836927 , PMID:22692975 copper atom affects binding EXP 6480464 HSPA5 protein binds to Copper CTD PMID:14534351 , PMID:15359738 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of HSPA5 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of HSPA5 protein CTD PMID:15836927 , PMID:22692975 copper(0) affects binding EXP 6480464 HSPA5 protein binds to Copper CTD PMID:14534351 , PMID:15359738 copper(II) chloride multiple interactions ISO RGD:2843 6480464 [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA more ... CTD PMID:20920558 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of HSPA5 mRNA CTD PMID:19549813 copper(II) sulfate affects localization ISO RGD:2843 6480464 Copper Sulfate affects the localization of HSPA5 protein CTD PMID:21815057 crocidolite asbestos increases expression ISO RGD:10742 6480464 Asbestos, Crocidolite results in increased expression of HSPA5 protein CTD PMID:24918270 crocidolite asbestos multiple interactions ISO RGD:10742 6480464 OGG1 protein mutant form promotes the reaction [Asbestos, Crocidolite results in increased expression of HSPA5 protein] CTD PMID:24918270 curcumin increases expression ISO RGD:10742 6480464 Curcumin results in increased expression of HSPA5 mRNA CTD PMID:18200517 curcumin increases expression EXP 6480464 Curcumin results in increased expression of HSPA5 mRNA CTD PMID:29723631 cycloheximide multiple interactions ISO RGD:2843 6480464 Cycloheximide inhibits the reaction [GIF 0010 results in increased expression of HSPA5 mRNA] more ... CTD PMID:17915553 , PMID:9742210 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein], Cycloheximide inhibits the reaction [plumbagin results in increased expression of HSPA5 protein] CTD PMID:26784903 , PMID:31276663 cyclophosphamide decreases expression ISO RGD:2843 6480464 Cyclophosphamide results in decreased expression of HSPA5 mRNA CTD PMID:11906922 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide metabolite results in increased expression of HSPA5 mRNA CTD PMID:24356939 cyclosporin A increases expression ISO RGD:10742 6480464 Cyclosporine results in increased expression of HSPA5 mRNA, Cyclosporine results in increased expression of HSPA5 protein CTD PMID:22155090 more ... cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPA5 mRNA CTD PMID:32152650 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of HSPA5 mRNA, Cyclosporine results in increased expression of HSPA5 protein CTD PMID:19159671 more ... cyclosporin A multiple interactions ISO RGD:10742 6480464 2-dimethylamino-4 more ... CTD PMID:22155090 cyclosporin A multiple interactions ISO RGD:2843 6480464 Melatonin promotes the reaction [Cyclosporine results in increased expression of HSPA5 protein] CTD PMID:20136702 cyclosporin A increases expression ISO RGD:2843 6480464 Cyclosporine results in increased expression of HSPA5 mRNA, Cyclosporine results in increased expression of HSPA5 protein CTD PMID:20136702 , PMID:25596134 cylindrospermopsin decreases expression EXP 6480464 cylindrospermopsin results in decreased expression of HSPA5 mRNA CTD PMID:24921660 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of HSPA5 mRNA CTD PMID:25424538 cytochalasin B increases expression ISO RGD:2843 6480464 Cytochalasin B results in increased expression of HSPA5 protein CTD PMID:26732598 D-glucose increases expression EXP 6480464 Glucose deficiency results in increased expression of HSPA5 mRNA more ... CTD PMID:12147617 more ... D-glucose increases expression ISO RGD:10742 6480464 Glucose results in increased expression of HSPA5 mRNA, Glucose results in increased expression of HSPA5 protein CTD PMID:30076216 D-glucose multiple interactions ISO RGD:10742 6480464 2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein] more ... CTD PMID:21705745 , PMID:30076216 D-glucose multiple interactions EXP 6480464 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA] more ... CTD PMID:25451566 , PMID:31022492 D-glucose decreases expression ISO RGD:2843 6480464 Glucose results in decreased expression of HSPA5 mRNA CTD PMID:24349266 D-glucose increases expression ISO RGD:2843 6480464 Glucose deficiency results in increased expression of HSPA5 protein CTD PMID:21337367 D-glucose decreases expression ISO RGD:10742 6480464 Glucose results in decreased expression of HSPA5 mRNA CTD PMID:17178593 D-mannopyranose multiple interactions EXP 6480464 Mannose inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein] CTD PMID:20593179 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of HSPA5 protein CTD PMID:19722195 , PMID:22843330 D-penicillamine multiple interactions ISO RGD:10742 6480464 Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of HSPA5 protein] CTD PMID:22945834 dantrolene multiple interactions EXP 6480464 Dantrolene inhibits the reaction [tributyltin results in increased expression of HSPA5 protein] CTD PMID:23743301 DDT increases expression EXP 6480464 DDT results in increased expression of HSPA5 mRNA CTD PMID:15710169 DDT increases expression ISO RGD:2843 6480464 DDT results in increased expression of HSPA5 mRNA CTD PMID:29477483 demethoxycurcumin multiple interactions EXP 6480464 demethoxycurcumin analog inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] CTD PMID:26264395 deoxycholic acid decreases response to substance EXP 6480464 HSPA5 protein results in decreased susceptibility to Deoxycholic Acid CTD PMID:12507930 deoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... CTD PMID:32152650 deoxynivalenol multiple interactions ISO RGD:10742 6480464 calpain inhibitor III inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein] more ... CTD PMID:10652249 , PMID:19336499 deoxynivalenol increases phosphorylation ISO RGD:10742 6480464 deoxynivalenol results in increased phosphorylation of HSPA5 protein CTD PMID:23811945 deoxynivalenol decreases expression ISO RGD:10742 6480464 deoxynivalenol results in decreased expression of HSPA5 mRNA CTD PMID:10652249 deoxynivalenol decreases expression EXP 6480464 deoxynivalenol results in decreased expression of HSPA5 mRNA CTD PMID:20682335 , PMID:24356939 diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of HSPA5 protein CTD PMID:19550292 diamminedichloroplatinum decreases expression EXP 6480464 transplatin results in decreased expression of HSPA5 mRNA CTD PMID:11099651 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of HSPA5 mRNA CTD PMID:24356939 , PMID:25424538 diarsenic trioxide increases expression ISO RGD:2843 6480464 Arsenic Trioxide results in increased expression of HSPA5 protein CTD PMID:21145380 diarsenic trioxide multiple interactions ISO RGD:10742 6480464 1 more ... CTD PMID:21533816 more ... diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of HSPA5 mRNA, Arsenic Trioxide results in increased expression of HSPA5 protein CTD PMID:11678611 more ... diarsenic trioxide multiple interactions ISO RGD:2843 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein] CTD PMID:21145380 diarsenic trioxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]] more ... CTD PMID:11678611 more ... diarsenic trioxide affects response to substance EXP 6480464 HSPA5 protein affects the susceptibility to Arsenic Trioxide CTD PMID:19695276 diarsenic trioxide increases expression ISO RGD:10742 6480464 Arsenic Trioxide results in increased expression of HSPA5 mRNA, Arsenic Trioxide results in increased expression of HSPA5 protein CTD PMID:21533816 more ... diazinon increases expression ISO RGD:10742 6480464 Diazinon results in increased expression of HSPA5 protein CTD PMID:19647006 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of HSPA5 mRNA CTD PMID:24356939 dibutyl phthalate increases expression ISO RGD:10742 6480464 Dibutyl Phthalate results in increased expression of HSPA5 protein CTD PMID:26804720 dibutyl phthalate increases expression ISO RGD:2843 6480464 Dibutyl Phthalate results in increased expression of HSPA5 protein CTD PMID:26804720 dibutyl phthalate multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein] CTD PMID:26804720 dibutyl phthalate multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein] CTD PMID:26804720 dichlorine multiple interactions ISO RGD:2843 6480464 [Ozone co-treated with Chlorine] results in decreased expression of HSPA5 mRNA CTD PMID:18636392 diclofenac increases expression ISO RGD:2843 6480464 Diclofenac results in increased expression of HSPA5 mRNA CTD PMID:25014874 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of HSPA5 mRNA CTD PMID:27313093 diclofenac multiple interactions ISO RGD:2843 6480464 [Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of HSPA5 protein CTD PMID:25772430 dicoumarol multiple interactions EXP 6480464 Dicumarol inhibits the reaction [1-nitropyrene results in increased expression of HSPA5 protein] CTD PMID:19460413 Dienochlor decreases expression EXP 6480464 dienochlor results in decreased expression of HSPA5 protein CTD PMID:16884889 diethyl maleate decreases reduction ISO RGD:10742 6480464 diethyl maleate results in decreased reduction of HSPA5 protein CTD PMID:19843705 dihydrocapsaicin increases expression EXP 6480464 dihydrocapsaicin results in increased expression of HSPA5 protein CTD PMID:19139269 dimethylarsinic acid increases expression ISO RGD:2843 6480464 Cacodylic Acid results in increased expression of HSPA5 mRNA CTD PMID:16122865 dioscin multiple interactions ISO RGD:10742 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] CTD PMID:24146112 dioscin multiple interactions ISO RGD:2843 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] CTD PMID:24146112 dioxygen multiple interactions ISO RGD:2843 6480464 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 mRNA] more ... CTD PMID:22226148 dioxygen decreases expression ISO RGD:10742 6480464 Oxygen deficiency results in decreased expression of HSPA5 protein CTD PMID:25937538 dioxygen affects expression EXP 6480464 Oxygen deficiency affects the expression of HSPA5 mRNA CTD PMID:25596134 dioxygen increases expression ISO RGD:10742 6480464 Oxygen deficiency results in increased expression of HSPA5 protein CTD PMID:24680926 dioxygen increases expression ISO RGD:2843 6480464 Oxygen deficiency results in increased expression of HSPA5 mRNA, Oxygen deficiency results in increased expression of HSPA5 protein CTD PMID:21337367 , PMID:22226148 dioxygen multiple interactions EXP 6480464 Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein] CTD PMID:20593179 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of HSPA5 protein CTD PMID:28161410 diuron decreases expression ISO RGD:2843 6480464 Diuron results in decreased expression of HSPA5 mRNA CTD PMID:21551480 dopamine increases expression EXP 6480464 Dopamine results in increased expression of HSPA5 protein CTD PMID:24675778 dorsomorphin multiple interactions ISO RGD:2843 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]] CTD PMID:31433112 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of HSPA5 mRNA CTD PMID:17680992 , PMID:29803840 doxorubicin decreases expression ISO RGD:2843 6480464 Doxorubicin results in decreased expression of HSPA5 mRNA CTD PMID:30261314 doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of HSPA5 protein CTD PMID:29385562 doxorubicin increases expression ISO RGD:2843 6480464 Doxorubicin results in increased expression of HSPA5 protein CTD PMID:28495616 doxorubicin multiple interactions ISO RGD:2843 6480464 1-2-3-4-methoxyphenylpropoxy-4-methoxyphenylethyl-1H-imidazole inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein], salvianolic acid B inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] CTD PMID:28495616 doxorubicin multiple interactions EXP 6480464 Doxorubicin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] CTD PMID:16298333 edaravone multiple interactions ISO RGD:2843 6480464 Edaravone promotes the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 protein] CTD PMID:21429313 elemental carbon multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased expression of HSPA5 mRNA, [Air Pollutants results in increased abundance of Carbon] which results in increased expression of HSPA5 mRNA CTD PMID:31268311 emodin increases expression ISO RGD:2843 6480464 Emodin results in increased expression of HSPA5 protein CTD PMID:19549930 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of HSPA5 protein CTD PMID:16884889 endosulfan increases expression ISO RGD:2843 6480464 Endosulfan results in increased expression of HSPA5 mRNA, Endosulfan results in increased expression of HSPA5 protein CTD PMID:31464424 endosulfan affects expression ISO RGD:2843 6480464 Endosulfan affects the expression of HSPA5 mRNA CTD PMID:29391264 enniatin multiple interactions EXP 6480464 [beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA CTD PMID:31100301 enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HSPA5 protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:10742 6480464 Cimetidine inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] more ... CTD PMID:24146112 more ... ethanol affects expression ISO RGD:10742 6480464 Ethanol affects the expression of HSPA5 mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] CTD PMID:24224909 ethanol increases expression EXP 6480464 Ethanol results in increased expression of HSPA5 protein CTD PMID:24224909 ethanol decreases expression ISO RGD:2843 6480464 Ethanol results in decreased expression of HSPA5 protein CTD PMID:23200777 , PMID:24646710 ethanol increases expression ISO RGD:2843 6480464 Ethanol results in increased expression of HSPA5 mRNA, Ethanol results in increased expression of HSPA5 protein CTD PMID:24146112 , PMID:28119953 ethanol multiple interactions ISO RGD:2843 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] CTD PMID:24146112 ethanol increases expression ISO RGD:10742 6480464 Ethanol results in increased expression of HSPA5 mRNA, Ethanol results in increased expression of HSPA5 protein CTD PMID:18377926 more ... ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of HSPA5 protein CTD PMID:12183065 fangchinoline increases expression EXP 6480464 fangchinoline results in increased expression of HSPA5 protein CTD PMID:28754437 fangchinoline multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of HSPA5 protein] CTD PMID:28754437 fenofibrate decreases expression ISO RGD:2843 6480464 Fenofibrate results in decreased expression of HSPA5 mRNA CTD PMID:25596134 fisetin multiple interactions EXP 6480464 1 more ... CTD PMID:28181380 fisetin increases expression EXP 6480464 fisetin results in increased expression of HSPA5 protein CTD PMID:28181380 flavokawain B increases expression EXP 6480464 flavokawain B results in increased expression of HSPA5 protein CTD PMID:30025493 fluoranthene multiple interactions ISO RGD:10742 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA5 mRNA CTD PMID:28329830 fluorescein 5-isothiocyanate affects binding EXP 6480464 Fluorescein-5-isothiocyanate binds to HSPA5 protein CTD PMID:27129696 folic acid multiple interactions ISO RGD:10742 6480464 [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HSPA5 protein more ... CTD PMID:20938992 more ... folic acid decreases expression ISO RGD:10742 6480464 Folic Acid results in decreased expression of HSPA5 mRNA CTD PMID:25629700 folic acid decreases expression EXP 6480464 Folic Acid deficiency results in decreased expression of HSPA5 protein CTD PMID:28639913 formetanate increases expression EXP 6480464 formetanate results in increased expression of HSPA5 protein CTD PMID:16271832 fructose increases expression ISO RGD:10742 6480464 Fructose results in increased expression of HSPA5 mRNA, Fructose results in increased expression of HSPA5 protein CTD PMID:22698815 fructose multiple interactions ISO RGD:10742 6480464 Phenylbutyrates inhibits the reaction [Fructose results in increased expression of HSPA5 protein] CTD PMID:22698815 fulvestrant multiple interactions ISO RGD:10742 6480464 [Chlordecone co-treated with fulvestrant] results in increased expression of HSPA5 protein CTD PMID:17640991 fumonisin B1 increases expression EXP 6480464 fumonisin B1 results in increased expression of HSPA5 mRNA, fumonisin B1 results in increased expression of HSPA5 protein CTD PMID:31891755 fumonisin B1 multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein], thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein] CTD PMID:31891755 furan affects binding ISO RGD:2843 6480464 furan binds to HSPA5 protein CTD PMID:22240984 furan decreases expression ISO RGD:2843 6480464 furan results in decreased expression of HSPA5 mRNA CTD PMID:26194646 Fusarenone X decreases expression EXP 6480464 fusarenon-X results in decreased expression of HSPA5 mRNA CTD PMID:20682335 gadolinium atom multiple interactions ISO RGD:10742 6480464 Gadolinium inhibits the reaction [Glucose results in increased expression of HSPA5 protein] CTD PMID:30076216 gadolinium trichloride increases expression ISO RGD:2843 6480464 gadolinium chloride results in increased expression of HSPA5 protein CTD PMID:21198628 gadolinium trichloride multiple interactions ISO RGD:2843 6480464 Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of HSPA5 protein] CTD PMID:21198628 gadolinium trichloride affects expression ISO RGD:2843 6480464 gadolinium chloride affects the expression of HSPA5 mRNA CTD PMID:21198628 galactose multiple interactions EXP 6480464 Phycocyanin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] CTD PMID:23036742 galactose increases expression EXP 6480464 Galactose results in increased expression of HSPA5 protein CTD PMID:23036742 gedunin increases expression EXP 6480464 gedunin results in increased expression of HSPA5 mRNA CTD PMID:17010675 geldanamycin multiple interactions EXP 6480464 Bortezomib promotes the reaction [geldanamycin results in increased expression of HSPA5 protein], geldanamycin promotes the reaction [Bortezomib results in increased expression of HSPA5 protein] CTD PMID:15141013 geldanamycin increases expression EXP 6480464 geldanamycin results in increased expression of HSPA5 protein CTD PMID:15141013 geldanamycin affects expression EXP 6480464 geldanamycin affects the expression of HSPA5 protein CTD PMID:14576064 gemcitabine increases expression EXP 6480464 gemcitabine results in increased expression of HSPA5 mRNA CTD PMID:17039268 gentamycin increases expression ISO RGD:2843 6480464 Gentamicins results in increased expression of HSPA5 mRNA, Gentamicins results in increased expression of HSPA5 protein CTD PMID:17567590 more ... gentamycin multiple interactions ISO RGD:10742 6480464 ursodoxicoltaurine inhibits the reaction [Gentamicins results in increased expression of HSPA5 mRNA], ursodoxicoltaurine inhibits the reaction [Gentamicins results in increased expression of HSPA5 protein] CTD PMID:29751043 gentamycin increases expression ISO RGD:10742 6480464 Gentamicins results in increased expression of HSPA5 mRNA, Gentamicins results in increased expression of HSPA5 protein CTD PMID:29751043 ginsenoside Rg1 multiple interactions EXP 6480464 ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] CTD PMID:30918470 glafenine increases expression ISO RGD:2843 6480464 Glafenine results in increased expression of HSPA5 mRNA CTD PMID:24136188 glucose increases expression EXP 6480464 Glucose deficiency results in increased expression of HSPA5 mRNA more ... CTD PMID:12147617 more ... glucose increases expression ISO RGD:10742 6480464 Glucose results in increased expression of HSPA5 mRNA, Glucose results in increased expression of HSPA5 protein CTD PMID:30076216 glucose multiple interactions ISO RGD:10742 6480464 2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of HSPA5 protein] more ... CTD PMID:21705745 , PMID:30076216 glucose multiple interactions EXP 6480464 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 mRNA] more ... CTD PMID:25451566 , PMID:31022492 glucose decreases expression ISO RGD:2843 6480464 Glucose results in decreased expression of HSPA5 mRNA CTD PMID:24349266 glucose increases expression ISO RGD:2843 6480464 Glucose deficiency results in increased expression of HSPA5 protein CTD PMID:21337367 glucose decreases expression ISO RGD:10742 6480464 Glucose results in decreased expression of HSPA5 mRNA CTD PMID:17178593 glutathione multiple interactions ISO RGD:10742 6480464 Glutathione inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein], Glutathione inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] CTD PMID:20493918 glycine multiple interactions EXP 6480464 Glycine inhibits the reaction [Homocysteine results in increased expression of HSPA5 mRNA] CTD PMID:27064126 glycine betaine decreases expression ISO RGD:10742 6480464 Betaine results in decreased expression of HSPA5 mRNA CTD PMID:22945834 glycochenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... CTD PMID:32152650 glycocholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... CTD PMID:32152650 glycodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA more ... CTD PMID:32152650 glyphosate increases methylation ISO RGD:2843 6480464 glyphosate results in increased methylation of HSPA5 gene CTD PMID:31011160 graphene oxide decreases expression ISO RGD:10742 6480464 graphene oxide analog results in decreased expression of HSPA5 mRNA CTD PMID:33227293 graphite increases expression EXP 6480464 Graphite results in increased expression of HSPA5 protein CTD PMID:22157353 Guanabenz multiple interactions ISO RGD:2843 6480464 Guanabenz inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] CTD PMID:24892553 Guanabenz multiple interactions ISO RGD:10742 6480464 Guanabenz inhibits the reaction [Acetaminophen results in increased expression of HSPA5 protein] CTD PMID:31524377 GW 4064 multiple interactions ISO RGD:10742 6480464 GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of HSPA5 mRNA] CTD PMID:28223344 hexadecanoic acid increases expression ISO RGD:2843 6480464 Palmitic Acid results in increased expression of HSPA5 mRNA CTD PMID:24349266 hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of HSPA5 mRNA CTD PMID:30547786 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of HSPA5 protein CTD PMID:30738135 hexadecanoic acid multiple interactions ISO RGD:10742 6480464 obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein], trigonelline inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein] CTD PMID:26655953 , PMID:30208301 hexadecanoic acid increases expression ISO RGD:10742 6480464 Palmitic Acid results in increased expression of HSPA5 protein CTD PMID:26655953 , PMID:30208301 homocysteine multiple interactions EXP 6480464 Glycine inhibits the reaction [Homocysteine results in increased expression of HSPA5 mRNA] CTD PMID:27064126 homocysteine increases expression EXP 6480464 Homocysteine results in increased expression of HSPA5 mRNA, Homocysteine results in increased expression of HSPA5 protein CTD PMID:19960509 , PMID:27064126 hyaluronic acid affects expression ISO RGD:2843 6480464 Hyaluronic Acid analog affects the expression of HSPA5 protein CTD PMID:23178681 hyaluronic acid multiple interactions ISO RGD:2843 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of HSPA5 protein] CTD PMID:23178681 hydralazine multiple interactions ISO RGD:10742 6480464 Hydralazine inhibits the reaction [Ethanol results in increased expression of HSPA5 mRNA] CTD PMID:28119953 hydrazine increases expression ISO RGD:2843 6480464 hydrazine results in increased expression of HSPA5 mRNA, hydrazine results in increased expression of HSPA5 protein CTD PMID:15370871 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of HSPA5 protein CTD PMID:22269385 , PMID:23885834 hydrogen peroxide increases expression ISO RGD:2843 6480464 Hydrogen Peroxide results in increased expression of HSPA5 protein CTD PMID:22934841 hydrogen peroxide decreases expression ISO RGD:2843 6480464 Hydrogen Peroxide results in decreased expression of HSPA5 protein CTD PMID:23178681 hydrogen peroxide multiple interactions ISO RGD:2843 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of HSPA5 protein] CTD PMID:23178681 hydroxytyrosol multiple interactions ISO RGD:2843 6480464 3 more ... CTD PMID:29414845 ibuprofen decreases expression EXP 6480464 Ibuprofen results in decreased expression of HSPA5 mRNA CTD PMID:25596134 ibuprofen decreases expression ISO RGD:2843 6480464 Ibuprofen results in decreased expression of HSPA5 mRNA CTD PMID:25596134 icosanoid multiple interactions ISO RGD:2843 6480464 Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of HSPA5 mRNA], Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of HSPA5 protein] CTD PMID:23603837 imidacloprid decreases expression EXP 6480464 imidacloprid results in decreased expression of HSPA5 protein CTD PMID:16884889 indometacin multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Indomethacin results in increased expression of HSPA5 protein] more ... CTD PMID:17341418 indometacin increases expression ISO RGD:2843 6480464 Indomethacin results in increased expression of HSPA5 mRNA CTD PMID:18799549 indometacin increases expression ISO RGD:10742 6480464 Indomethacin results in increased expression of HSPA5 mRNA CTD PMID:18799549 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of HSPA5 protein CTD PMID:17341418 indoxyl sulfate increases expression ISO RGD:10742 6480464 Indican results in increased expression of HSPA5 mRNA CTD PMID:29380555 iodide salt decreases expression ISO RGD:2843 6480464 Iodides deficiency results in decreased expression of HSPA5 protein CTD PMID:26795019 ionomycin multiple interactions ISO RGD:10742 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 mRNA more ... CTD PMID:10652249 iprodione increases expression EXP 6480464 iprodione results in increased expression of HSPA5 mRNA CTD PMID:16696176 isoflavones multiple interactions ISO RGD:2843 6480464 [9 more ... CTD PMID:22248470 isoprenaline increases expression ISO RGD:10742 6480464 Isoproterenol results in increased expression of HSPA5 mRNA CTD PMID:21335049 isoprenaline multiple interactions ISO RGD:2843 6480464 [Acrolein results in increased susceptibility to Isoproterenol] which results in increased expression of HSPA5 protein more ... CTD PMID:29414845 isoprenaline increases expression ISO RGD:2843 6480464 Isoproterenol results in increased expression of HSPA5 mRNA CTD PMID:29414845 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of HSPA5 mRNA CTD PMID:24286936 ivermectin increases expression EXP 6480464 Ivermectin results in increased expression of HSPA5 protein CTD PMID:30738135 ketamine decreases expression ISO RGD:2843 6480464 Ketamine results in decreased expression of HSPA5 mRNA CTD PMID:20080153 KN-93 multiple interactions ISO RGD:2843 6480464 KN 93 inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] CTD PMID:29883672 kojic acid multiple interactions ISO RGD:2843 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA CTD PMID:18544905 L-1,4-dithiothreitol increases expression EXP 6480464 Dithiothreitol metabolite results in increased expression of HSPA5 protein more ... CTD PMID:15710169 more ... L-1,4-dithiothreitol increases expression ISO RGD:2843 6480464 Dithiothreitol metabolite results in increased expression of HSPA5 protein CTD PMID:17416481 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased expression of HSPA5 protein] CTD PMID:17353921 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of HSPA5 mRNA CTD PMID:19197388 L-methionine multiple interactions ISO RGD:10742 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HSPA5 gene more ... CTD PMID:20938992 , PMID:23038002 lactacystin multiple interactions EXP 6480464 HSPA5 promotes the reaction [lactacystin results in increased expression of APOB protein] more ... CTD PMID:15618547 lanthanum atom multiple interactions EXP 6480464 Lanthanum binds to and results in increased expression of HSPA5 protein CTD PMID:18773883 lead diacetate multiple interactions ISO RGD:2843 6480464 ATP7A protein modified form inhibits the reaction [lead acetate binds to HSPA5 protein] more ... CTD PMID:10702365 more ... lead diacetate increases expression ISO RGD:2843 6480464 lead acetate results in increased expression of HSPA5 mRNA, lead acetate results in increased expression of HSPA5 protein CTD PMID:10702365 more ... lead diacetate affects localization ISO RGD:2843 6480464 lead acetate affects the localization of HSPA5 protein CTD PMID:21815057 lead diacetate affects binding ISO RGD:2843 6480464 lead acetate binds to HSPA5 protein CTD PMID:10702365 lead diacetate affects expression ISO RGD:2843 6480464 lead acetate affects the expression of HSPA5 mRNA CTD PMID:15111246 lead nitrate increases expression ISO RGD:10742 6480464 lead nitrate results in increased expression of HSPA5 protein CTD PMID:20435106 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of HSPA5 mRNA CTD PMID:14971657 lead(0) affects expression ISO RGD:2843 6480464 Lead affects the expression of HSPA5 mRNA CTD PMID:15111246 lead(0) increases expression ISO RGD:2843 6480464 Lead results in increased expression of HSPA5 protein CTD PMID:19161237 , PMID:24431214 lead(0) affects localization ISO RGD:2843 6480464 Lead affects the localization of HSPA5 protein CTD PMID:24431214 lead(0) increases expression EXP 6480464 Lead results in increased expression of HSPA5 mRNA CTD PMID:11032763 lead(0) multiple interactions ISO RGD:2843 6480464 HSPA5 protein affects the reaction [Lead results in decreased expression of OCLN protein] more ... CTD PMID:15111246 , PMID:24431214 lead(2+) increases expression EXP 6480464 Lead results in increased expression of HSPA5 mRNA CTD PMID:11032763 lead(2+) increases expression ISO RGD:2843 6480464 Lead results in increased expression of HSPA5 protein CTD PMID:19161237 , PMID:24431214 lead(2+) affects localization ISO RGD:2843 6480464 Lead affects the localization of HSPA5 protein CTD PMID:24431214 lead(2+) affects expression ISO RGD:2843 6480464 Lead affects the expression of HSPA5 mRNA CTD PMID:15111246 lead(2+) multiple interactions ISO RGD:2843 6480464 HSPA5 protein affects the reaction [Lead results in decreased expression of OCLN protein] more ... CTD PMID:15111246 , PMID:24431214 lead(II) chloride decreases expression EXP 6480464 lead chloride results in decreased expression of HSPA5 protein CTD PMID:24419708 lead(II) chloride increases expression ISO RGD:2843 6480464 lead chloride results in increased expression of HSPA5 protein CTD PMID:19720107 , PMID:21073006 lead(II) chloride affects localization ISO RGD:2843 6480464 lead chloride affects the localization of HSPA5 protein CTD PMID:19720107 linagliptin multiple interactions ISO RGD:10742 6480464 Linagliptin inhibits the reaction [Cisplatin results in increased expression of HSPA5 mRNA] CTD PMID:32567747 linoleic acid increases expression ISO RGD:10742 6480464 Linoleic Acid analog results in increased expression of HSPA5 protein CTD PMID:27939595 lipoic acid multiple interactions ISO RGD:10742 6480464 Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of HSPA5 protein] CTD PMID:23892647 lipoic acid multiple interactions ISO RGD:2843 6480464 Thioctic Acid inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] CTD PMID:30605698 lipopolysaccharide multiple interactions EXP 6480464 3-methyladenine promotes the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein] more ... CTD PMID:22777745 more ... lipopolysaccharide increases expression ISO RGD:10742 6480464 Lipopolysaccharides results in increased expression of HSPA5 protein CTD PMID:28245985 lipopolysaccharide multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 mRNA] more ... CTD PMID:28844859 lipopolysaccharide multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein], Vaticanol B inhibits the reaction [Lipopolysaccharides affects the localization of HSPA5 protein] CTD PMID:17475668 , PMID:28245985 lipopolysaccharide decreases expression ISO RGD:10742 6480464 Lipopolysaccharides results in decreased expression of HSPA5 protein CTD PMID:21355878 lipopolysaccharide affects localization ISO RGD:10742 6480464 Lipopolysaccharides affects the localization of HSPA5 protein CTD PMID:17475668 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of HSPA5 protein CTD PMID:19675143 more ... lithium atom multiple interactions ISO RGD:2843 6480464 [Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 mRNA more ... CTD PMID:21429313 lithium atom increases expression ISO RGD:2843 6480464 Lithium results in increased expression of HSPA5 mRNA, Lithium results in increased expression of HSPA5 protein CTD PMID:16236328 , PMID:18296634 lithium hydride multiple interactions ISO RGD:2843 6480464 [Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 mRNA more ... CTD PMID:21429313 lithium hydride increases expression ISO RGD:2843 6480464 Lithium results in increased expression of HSPA5 mRNA, Lithium results in increased expression of HSPA5 protein CTD PMID:16236328 , PMID:18296634 losartan multiple interactions ISO RGD:2843 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of HSPA5 protein] CTD PMID:25398788 luteolin multiple interactions ISO RGD:10742 6480464 Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA], Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] CTD PMID:32407927 luteolin multiple interactions EXP 6480464 Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] CTD PMID:32407927 LY294002 multiple interactions ISO RGD:10742 6480464 [2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased expression of HSPA5 protein CTD PMID:24898257 LY294002 multiple interactions ISO RGD:2843 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]] CTD PMID:31433112 LY294002 multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] CTD PMID:19428936 lycopene multiple interactions ISO RGD:2843 6480464 Lycopene inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] CTD PMID:32544411 maneb multiple interactions ISO RGD:10742 6480464 [Paraquat co-treated with Maneb] results in increased expression of HSPA5 mRNA CTD PMID:18386188 manganese atom increases expression EXP 6480464 Manganese results in increased expression of HSPA5 protein CTD PMID:21477646 manganese atom multiple interactions ISO RGD:2843 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of HSPA5 mRNA CTD PMID:32574669 manganese(0) increases expression EXP 6480464 Manganese results in increased expression of HSPA5 protein CTD PMID:21477646 manganese(0) multiple interactions ISO RGD:2843 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of HSPA5 mRNA CTD PMID:32574669 manganese(II) chloride multiple interactions ISO RGD:2843 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of HSPA5 mRNA more ... CTD PMID:23934647 , PMID:32574669 manganese(II) chloride increases expression ISO RGD:2843 6480464 manganese chloride results in increased expression of HSPA5 mRNA, manganese chloride results in increased expression of HSPA5 protein CTD PMID:23934647 more ... meglumine amidotrizoate increases expression ISO RGD:2843 6480464 Diatrizoate Meglumine results in increased expression of HSPA5 protein CTD PMID:20071420 melatonin multiple interactions ISO RGD:2843 6480464 Melatonin inhibits the reaction [Aluminum Chloride results in increased expression of HSPA5 protein] more ... CTD PMID:20136702 more ... menadione multiple interactions EXP 6480464 Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein], S 3483 promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein] CTD PMID:19819344 menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of HSPA5 protein CTD PMID:19819344 menaquinone decreases expression EXP 6480464 Vitamin K 2 results in decreased expression of HSPA5 protein CTD PMID:29432837 mercury atom multiple interactions ISO RGD:2843 6480464 Mercury promotes the reaction [HSPA5 protein binds to FOS enhancer] more ... CTD PMID:15111246 mercury atom affects expression ISO RGD:2843 6480464 Mercury affects the expression of HSPA5 mRNA CTD PMID:15111246 mercury dichloride multiple interactions ISO RGD:2843 6480464 Cycloheximide inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein] more ... CTD PMID:15111246 , PMID:17915553 mercury dichloride increases expression ISO RGD:10742 6480464 Mercuric Chloride results in increased expression of HSPA5 protein CTD PMID:32879258 mercury dichloride multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein] CTD PMID:32879258 mercury dichloride increases expression ISO RGD:2843 6480464 Mercuric Chloride results in increased expression of HSPA5 mRNA, Mercuric Chloride results in increased expression of HSPA5 protein CTD PMID:17915553 , PMID:30807803 mercury dichloride affects expression ISO RGD:2843 6480464 Mercuric Chloride affects the expression of HSPA5 mRNA CTD PMID:15111246 mercury(0) multiple interactions ISO RGD:2843 6480464 Mercury promotes the reaction [HSPA5 protein binds to FOS enhancer] more ... CTD PMID:15111246 mercury(0) affects expression ISO RGD:2843 6480464 Mercury affects the expression of HSPA5 mRNA CTD PMID:15111246 metformin increases expression ISO RGD:2843 6480464 Metformin results in increased expression of HSPA5 mRNA CTD PMID:25596134 methamphetamine increases expression ISO RGD:10742 6480464 Methamphetamine results in increased expression of HSPA5 protein CTD PMID:27323860 , PMID:32203791 methamphetamine multiple interactions ISO RGD:2843 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of HSPA5 mRNA more ... CTD PMID:19564919 , PMID:28070110 methamphetamine increases expression ISO RGD:2843 6480464 Methamphetamine results in increased expression of HSPA5 mRNA, Methamphetamine results in increased expression of HSPA5 protein CTD PMID:19564919 , PMID:28070110 methamphetamine multiple interactions EXP 6480464 1-6-3-methoxyestra-1 more ... CTD PMID:27323860 more ... methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of HSPA5 mRNA, Methamphetamine results in increased expression of HSPA5 protein CTD PMID:27323860 , PMID:33421459 methamphetamine affects expression ISO RGD:2843 6480464 Methamphetamine affects the expression of HSPA5 protein CTD PMID:19826936 methapyrilene increases expression ISO RGD:2843 6480464 Methapyrilene results in increased expression of HSPA5 mRNA CTD PMID:15120968 , PMID:17450226 methomyl increases expression EXP 6480464 Methomyl results in increased expression of HSPA5 protein CTD PMID:16271832 methyl beta-cyclodextrin multiple interactions EXP 6480464 methyl-beta-cyclodextrin inhibits the reaction [1-pentyl-1H-indol-3-yl2 more ... CTD PMID:30502353 methylmercury chloride increases expression ISO RGD:10742 6480464 methylmercuric chloride results in increased expression of HSPA5 mRNA, methylmercuric chloride results in increased expression of HSPA5 protein CTD PMID:31330229 methylmercury chloride multiple interactions ISO RGD:10742 6480464 Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSPA5 protein] more ... CTD PMID:31330229 methylparaben increases expression EXP 6480464 methylparaben results in increased expression of HSPA5 mRNA CTD PMID:31745603 methylseleninic acid multiple interactions EXP 6480464 HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK1 protein] more ... CTD PMID:16204082 , PMID:16205645 methylseleninic acid increases expression EXP 6480464 methylselenic acid results in increased expression of HSPA5 mRNA, methylselenic acid results in increased expression of HSPA5 protein CTD PMID:16204082 more ... metyrapone multiple interactions EXP 6480464 Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein] CTD PMID:19819344 microcystin increases expression ISO RGD:2843 6480464 Microcystins results in increased expression of HSPA5 protein CTD PMID:22430071 microcystin RR increases expression ISO RGD:10742 6480464 microcystin RR results in increased expression of HSPA5 protein CTD PMID:20196164 minocycline multiple interactions ISO RGD:2843 6480464 Minocycline inhibits the reaction [Paraquat results in increased expression of HSPA5 protein] CTD PMID:22245251 mithramycin multiple interactions EXP 6480464 Plicamycin inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein] CTD PMID:26784903 Monobutylphthalate increases expression ISO RGD:10742 6480464 monobutyl phthalate results in increased expression of HSPA5 protein CTD PMID:20553848 monosodium L-glutamate increases expression ISO RGD:2843 6480464 Sodium Glutamate results in increased expression of HSPA5 mRNA CTD PMID:28954212 morusin increases expression EXP 6480464 morusin results in increased expression of HSPA5 protein CTD PMID:29421517 morusin multiple interactions EXP 6480464 4 more ... CTD PMID:29421517 mycophenolic acid decreases expression EXP 6480464 Mycophenolic Acid results in decreased expression of HSPA5 mRNA CTD PMID:24356939 myriocin multiple interactions EXP 6480464 thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein] CTD PMID:31891755 N,N-dimethylformamide multiple interactions ISO RGD:2843 6480464 [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA, [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 protein CTD PMID:20097184 N-acetyl-L-cysteine multiple interactions EXP 6480464 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris1 more ... CTD PMID:24802810 more ... N-acetyl-L-cysteine decreases expression ISO RGD:2843 6480464 Acetylcysteine results in decreased expression of HSPA5 protein CTD PMID:27484784 N-acetyl-L-cysteine multiple interactions ISO RGD:2843 6480464 Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA] more ... CTD PMID:21145380 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:10742 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA] more ... CTD PMID:20493918 more ... N-acetyl-L-cysteine increases expression EXP 6480464 Acetylcysteine results in increased expression of HSPA5 protein CTD PMID:19722195 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of HSPA5 protein CTD PMID:19139269 , PMID:21692457 N-hexadecanoylsphingosine multiple interactions ISO RGD:10742 6480464 [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of HSPA5 mRNA more ... CTD PMID:28223344 N-hexadecanoylsphingosine increases expression ISO RGD:10742 6480464 N-palmitoylsphingosine results in increased expression of HSPA5 mRNA CTD PMID:28223344 N-methyl-4-phenylpyridinium increases expression ISO RGD:2843 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 mRNA, 1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein CTD PMID:16026605 more ... N-methyl-4-phenylpyridinium multiple interactions ISO RGD:2843 6480464 Nicotine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein], TXN protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] CTD PMID:24140863 , PMID:28082123 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 chikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein], TXN protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein] CTD PMID:24140863 , PMID:25073091 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein CTD PMID:24675778 , PMID:25073091 N-methylnicotinate multiple interactions ISO RGD:10742 6480464 trigonelline inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein] CTD PMID:30208301 N-nitrosodiethylamine multiple interactions ISO RGD:2843 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA CTD PMID:18544905 N-nitrosodiethylamine decreases expression ISO RGD:2843 6480464 Diethylnitrosamine results in decreased expression of HSPA5 mRNA CTD PMID:11323195 N-nitrosomorpholine decreases expression ISO RGD:2843 6480464 N-nitrosomorpholine results in decreased expression of HSPA5 protein CTD PMID:19716841 naloxone increases expression EXP 6480464 Naloxone results in increased expression of HSPA5 protein CTD PMID:26377394 naltrexone multiple interactions EXP 6480464 Naltrexone inhibits the reaction [Methamphetamine results in increased expression of HSPA5 mRNA] CTD PMID:27323860 naphthalene affects binding ISO RGD:10742 6480464 naphthalene metabolite binds to HSPA5 protein CTD PMID:16206326 naphthalene increases reduction ISO RGD:10742 6480464 naphthalene results in increased reduction of HSPA5 protein CTD PMID:19843705 nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of HSPA5 mRNA CTD PMID:32152650 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of HSPA5 mRNA CTD PMID:32152650 nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of HSPA5, Nelfinavir results in increased expression of HSPA5 protein CTD PMID:19106637 more ... nelfinavir multiple interactions EXP 6480464 Tamoxifen promotes the reaction [Nelfinavir results in increased expression of HSPA5 protein] CTD PMID:20594311 nickel atom multiple interactions ISO RGD:2843 6480464 Nickel inhibits the reaction [lead acetate binds to HSPA5 protein] CTD PMID:10702365 nickel sulfate multiple interactions ISO RGD:2843 6480464 Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of HSPA5 mRNA] more ... CTD PMID:28296042 nickel sulfate increases expression ISO RGD:2843 6480464 nickel sulfate results in increased expression of HSPA5 mRNA, nickel sulfate results in increased expression of HSPA5 protein CTD PMID:28296042 nicotine increases expression EXP 6480464 Nicotine results in increased expression of HSPA5 CTD PMID:24201001 nicotine multiple interactions ISO RGD:10742 6480464 Nicotine inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28082123 nicotine multiple interactions ISO RGD:2843 6480464 Nicotine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein], Nicotine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] CTD PMID:18477628 , PMID:28082123 nifedipine multiple interactions ISO RGD:2843 6480464 Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 mRNA], Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 protein] CTD PMID:22226148 nilotinib increases expression EXP 6480464 4-methyl-N-3-4-methylimidazol-1-yl-5-trifluoromethylphenyl-3-4-pyridin-3-ylpyrimidin-2-ylaminobenzamide results in increased expression of HSPA5 mRNA CTD PMID:23883479 nilotinib multiple interactions EXP 6480464 arsenic trioxide promotes the reaction [4-methyl-N-3-4-methylimidazol-1-yl-5-trifluoromethylphenyl-3-4-pyridin-3-ylpyrimidin-2-ylaminobenzamide results in increased expression of HSPA5 mRNA] CTD PMID:23883479 nitric oxide multiple interactions EXP 6480464 [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 mRNA, [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in decreased expression of HSPA5 protein CTD PMID:19320461 Nivalenol decreases expression EXP 6480464 nivalenol results in decreased expression of HSPA5 mRNA CTD PMID:20682335 nocodazole increases expression ISO RGD:2843 6480464 Nocodazole results in increased expression of HSPA5 protein CTD PMID:26732598 Nodularin increases expression EXP 6480464 nodularin results in increased expression of HSPA5 mRNA CTD PMID:27061667 Nonidet P-40 decreases expression EXP 6480464 Nonidet P-40 results in decreased expression of HSPA5 mRNA CTD PMID:26552463 nonivamide multiple interactions EXP 6480464 [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of HSPA5 mRNA CTD PMID:17332266 nonivamide increases expression EXP 6480464 nonivamide results in increased expression of HSPA5 mRNA CTD PMID:17332266 Nonylphenol affects expression ISO RGD:2843 6480464 nonylphenol affects the expression of HSPA5 protein CTD PMID:19429228 Nonylphenol increases expression ISO RGD:2843 6480464 nonylphenol results in increased expression of HSPA5 mRNA CTD PMID:19429228 Norbinaltorphimine multiple interactions EXP 6480464 norbinaltorphimine inhibits the reaction [Methamphetamine results in increased expression of HSPA5 mRNA] CTD PMID:27323860 obeticholic acid multiple interactions ISO RGD:10742 6480464 obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein], obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein] CTD PMID:26655953 ochratoxin A decreases expression ISO RGD:10742 6480464 ochratoxin A results in decreased expression of HSPA5 protein CTD PMID:19445961 ochratoxin A decreases methylation EXP 6480464 ochratoxin A results in decreased methylation of HSPA5 promoter CTD PMID:30559759 ochratoxin A increases expression EXP 6480464 ochratoxin A metabolite results in increased expression of HSPA5 mRNA more ... CTD PMID:24356939 more ... ochratoxin A multiple interactions EXP 6480464 Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein] more ... CTD PMID:33465424 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of HSPA5 mRNA CTD PMID:19051279 okadaic acid increases expression ISO RGD:2843 6480464 Okadaic Acid results in increased expression of HSPA5 protein CTD PMID:26732598 oleanolic acid multiple interactions EXP 6480464 Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein], TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]] CTD PMID:33465424 oleic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of HSPA5 mRNA CTD PMID:30547786 oleic acid increases expression ISO RGD:2843 6480464 Oleic Acid results in increased expression of HSPA5 mRNA CTD PMID:24349266 oleuropein multiple interactions ISO RGD:2843 6480464 oleuropein inhibits the reaction [Acrolein results in increased expression of HSPA5 protein] CTD PMID:29414845 orlistat increases expression EXP 6480464 orlistat results in increased expression of HSPA5 mRNA CTD PMID:17283163 ouabain increases expression EXP 6480464 Ouabain results in increased expression of HSPA5 protein CTD PMID:31436044 oxaliplatin multiple interactions ISO RGD:2843 6480464 Lycopene inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] CTD PMID:32544411 oxaliplatin increases expression ISO RGD:2843 6480464 Oxaliplatin results in increased expression of HSPA5 mRNA CTD PMID:32544411 oxidopamine increases expression ISO RGD:2843 6480464 Oxidopamine results in increased expression of HSPA5 mRNA, Oxidopamine results in increased expression of HSPA5 protein CTD PMID:12486162 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of HSPA5 protein CTD PMID:26377394 oxycodone increases expression ISO RGD:2843 6480464 Oxycodone results in increased expression of HSPA5 protein CTD PMID:26377394 ozone multiple interactions ISO RGD:2843 6480464 [Ozone co-treated with Chlorine] results in decreased expression of HSPA5 mRNA CTD PMID:18636392 ozone increases phosphorylation ISO RGD:2843 6480464 Ozone results in increased phosphorylation of HSPA5 protein CTD PMID:33146391 ozone increases expression ISO RGD:10742 6480464 Ozone results in increased expression of HSPA5 mRNA CTD PMID:21543283 p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of HSPA5 mRNA, Menthol results in increased expression of HSPA5 protein CTD PMID:26760959 paclitaxel increases expression ISO RGD:2843 6480464 Paclitaxel results in increased expression of HSPA5 protein CTD PMID:26732598 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HSPA5 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO RGD:10742 6480464 Guanabenz inhibits the reaction [Acetaminophen results in increased expression of HSPA5 protein] CTD PMID:31524377 paracetamol increases expression ISO RGD:10742 6480464 Acetaminophen results in increased expression of HSPA5 protein CTD PMID:31524377 paracetamol affects expression ISO RGD:10742 6480464 Acetaminophen affects the expression of HSPA5 mRNA CTD PMID:15606129 , PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of HSPA5 mRNA, Paraquat results in increased expression of HSPA5 protein CTD PMID:19735704 more ... paraquat increases expression ISO RGD:10742 6480464 Paraquat results in increased expression of HSPA5 protein CTD PMID:27442881 paraquat increases expression ISO RGD:2843 6480464 Paraquat results in increased expression of HSPA5 mRNA, Paraquat results in increased expression of HSPA5 protein CTD PMID:17935786 more ... paraquat multiple interactions ISO RGD:10742 6480464 [Paraquat co-treated with Maneb] results in increased expression of HSPA5 mRNA CTD PMID:18386188 paraquat multiple interactions ISO RGD:2843 6480464 Minocycline inhibits the reaction [Paraquat results in increased expression of HSPA5 protein] more ... CTD PMID:22245251 , PMID:22678742 paraquat multiple interactions EXP 6480464 EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]] more ... CTD PMID:19735704 more ... patulin increases expression EXP 6480464 Patulin results in increased expression of HSPA5 protein CTD PMID:25577197 perfluorodecanoic acid increases metabolic processing ISO RGD:2843 6480464 perfluorodecanoic acid results in increased metabolism of HSPA5 protein CTD PMID:7958552 perfluorodecanoic acid increases phosphorylation ISO RGD:2843 6480464 perfluorodecanoic acid results in increased phosphorylation of HSPA5 protein CTD PMID:7880882 perfluorododecanoic acid affects expression ISO RGD:2843 6480464 perfluorododecanoic acid affects the expression of HSPA5 protein CTD PMID:26168851 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of HSPA5 mRNA CTD PMID:32790152 perfluorooctanoic acid decreases expression ISO RGD:10742 6480464 perfluorooctanoic acid results in decreased expression of HSPA5 mRNA CTD PMID:21318169 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of HSPA5 mRNA CTD PMID:32790152 perfluorooctanoic acid increases expression ISO RGD:10742 6480464 perfluorooctanoic acid results in increased expression of HSPA5 mRNA CTD PMID:32578922 perfluorooctanoic acid multiple interactions ISO RGD:10742 6480464 PPARA protein affects the reaction [perfluorooctanoic acid results in decreased expression of HSPA5 mRNA] CTD PMID:21318169 phenethyl caffeate multiple interactions ISO RGD:10742 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of HSPA5 mRNA more ... CTD PMID:28223344 PhIP increases expression ISO RGD:2843 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased expression of HSPA5 mRNA CTD PMID:15215175 phlorizin increases expression ISO RGD:10742 6480464 Phlorhizin results in increased expression of HSPA5 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10742 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 mRNA more ... CTD PMID:10652249 pirimicarb increases expression EXP 6480464 pirimicarb results in increased expression of HSPA5 protein CTD PMID:16271832 pirinixic acid multiple interactions ISO RGD:10742 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of HSPA5 mRNA] CTD PMID:21318169 pirinixic acid decreases expression ISO RGD:10742 6480464 pirinixic acid results in decreased expression of HSPA5 mRNA CTD PMID:21318169 , PMID:23811191 platycodin D increases expression EXP 6480464 platycodin D results in increased expression of HSPA5 mRNA CTD PMID:22784044 plumbagin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [plumbagin results in increased expression of HSPA5 protein], Cycloheximide inhibits the reaction [plumbagin results in increased expression of HSPA5 protein] CTD PMID:31276663 plumbagin increases expression EXP 6480464 plumbagin results in increased expression of HSPA5 protein CTD PMID:31276663 poly(guanylic acid) multiple interactions ISO RGD:2843 6480464 Poly G inhibits the reaction [Silicon Dioxide results in increased expression of HSPA5 protein] CTD PMID:31028789 potassium dichromate multiple interactions ISO RGD:2843 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of HSPA5 protein CTD PMID:30974164 potassium iodide multiple interactions EXP 6480464 Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 mRNA], Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein] CTD PMID:24231001 proanthocyanidin multiple interactions ISO RGD:2843 6480464 Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of HSPA5 protein] CTD PMID:25088297 procymidone decreases expression ISO RGD:2843 6480464 procymidone results in decreased expression of HSPA5 mRNA CTD PMID:15686871 progesterone affects expression ISO RGD:10742 6480464 Progesterone affects the expression of HSPA5 mRNA CTD PMID:17251523 propiconazole increases expression ISO RGD:10742 6480464 propiconazole results in increased expression of HSPA5 mRNA CTD PMID:21278054 pterostilbene increases expression EXP 6480464 pterostilbene results in increased expression of HSPA5 mRNA, pterostilbene results in increased expression of HSPA5 protein CTD PMID:25341683 pterostilbene multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein] more ... CTD PMID:25341683 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of HSPA5 mRNA, Pyrazinamide results in increased expression of HSPA5 protein CTD PMID:28063906 pyrazinecarboxamide multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein] CTD PMID:28063906 pyrazinecarboxamide increases expression ISO RGD:2843 6480464 Pyrazinamide results in increased expression of HSPA5 protein CTD PMID:28063906 pyrazinecarboxamide multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein] CTD PMID:28063906 pyrrolidine dithiocarbamate multiple interactions ISO RGD:2843 6480464 [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA more ... CTD PMID:20920558 quercetin multiple interactions EXP 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of HSPA5 mRNA more ... CTD PMID:19017364 more ... quercetin multiple interactions ISO RGD:2843 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of HSPA5 mRNA] CTD PMID:33038355 quercetin increases expression EXP 6480464 Quercetin results in increased expression of HSPA5 mRNA, Quercetin results in increased expression of HSPA5 protein CTD PMID:14750173 more ... quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of HSPA5 mRNA CTD PMID:21632981 quercetin decreases response to substance EXP 6480464 HSPA5 protein results in decreased susceptibility to Quercetin CTD PMID:19017364 quercetin affects expression ISO RGD:2843 6480464 Quercetin affects the expression of HSPA5 mRNA CTD PMID:18178720 rac-lactic acid multiple interactions EXP 6480464 HSPA5 protein affects the reaction [A2M protein modified form results in increased secretion of Lactic Acid] CTD PMID:25720493 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of HSPA5 mRNA, Resveratrol results in decreased expression of HSPA5 protein CTD PMID:20717957 resveratrol decreases expression ISO RGD:2843 6480464 resveratrol results in decreased expression of HSPA5 protein CTD PMID:24395567 resveratrol increases expression ISO RGD:10742 6480464 resveratrol results in increased expression of HSPA5 protein CTD PMID:25505154 resveratrol multiple interactions ISO RGD:2843 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]] more ... CTD PMID:26055348 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of HSPA5 protein CTD PMID:17914584 more ... resveratrol multiple interactions ISO RGD:10742 6480464 [resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] CTD PMID:21321189 resveratrol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [resveratrol results in increased expression of HSPA5 protein]] more ... CTD PMID:24149798 more ... rifampicin increases expression ISO RGD:2843 6480464 Rifampin results in increased expression of HSPA5 protein CTD PMID:24638036 rifampicin increases expression EXP 6480464 Rifampin results in increased expression of HSPA5 mRNA, Rifampin results in increased expression of HSPA5 protein CTD PMID:27470132 rifampicin multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 mRNA], 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 protein] CTD PMID:27470132 rifampicin multiple interactions ISO RGD:10742 6480464 [Rifampin co-treated with Cobicistat] results in increased expression of HSPA5 mRNA CTD PMID:33629115 rifampicin multiple interactions ISO RGD:2843 6480464 ATF4 mutant form inhibits the reaction [Rifampin results in increased expression of HSPA5 protein] CTD PMID:24638036 Riluzole increases expression EXP 6480464 Riluzole results in increased expression of HSPA5 protein CTD PMID:30280407 rimonabant multiple interactions EXP 6480464 [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of HSPA5 mRNA] CTD PMID:31054322 Roridin A multiple interactions ISO RGD:10742 6480464 roridin A results in increased degradation of and results in decreased expression of HSPA5 protein CTD PMID:19336499 rotenone multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] more ... CTD PMID:17459145 more ... rotenone increases oxidation ISO RGD:2843 6480464 Rotenone results in increased oxidation of HSPA5 protein CTD PMID:30951809 rotenone multiple interactions EXP 6480464 MIR384 mRNA promotes the reaction [Rotenone results in decreased expression of HSPA5 mRNA] CTD PMID:26864693 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of HSPA5 mRNA CTD PMID:26864693 rotenone increases expression ISO RGD:2843 6480464 Rotenone results in increased expression of HSPA5 mRNA, Rotenone results in increased expression of HSPA5 protein CTD PMID:26446018 , PMID:27016191 rotenone multiple interactions ISO RGD:2843 6480464 Resveratrol inhibits the reaction [Rotenone results in increased expression of HSPA5 mRNA], salubrinal inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] CTD PMID:26446018 , PMID:27016191 rotenone increases expression ISO RGD:10742 6480464 Rotenone results in increased expression of HSPA5 protein CTD PMID:17459145 , PMID:25428620 rottlerin increases expression EXP 6480464 rottlerin results in increased expression of HSPA5 protein CTD PMID:22410117 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of HSPA5 protein] CTD PMID:25341683 salubrinal multiple interactions EXP 6480464 EIF2S1 protein promotes the reaction [salubrinal inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]] more ... CTD PMID:19735704 more ... salubrinal multiple interactions ISO RGD:10742 6480464 salubrinal inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] CTD PMID:25428620 salubrinal increases expression ISO RGD:2843 6480464 salubrinal results in increased expression of HSPA5 protein CTD PMID:24932542 salubrinal multiple interactions ISO RGD:2843 6480464 salubrinal inhibits the reaction [Rotenone results in increased expression of HSPA5 protein] more ... CTD PMID:24932542 more ... salvianolic acid B multiple interactions ISO RGD:2843 6480464 salvianolic acid B inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] CTD PMID:28495616 saquinavir increases expression EXP 6480464 Saquinavir results in increased expression of HSPA5 protein CTD PMID:19147209 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Indomethacin results in increased expression of HSPA5 protein] CTD PMID:17341418 SCH 23390 multiple interactions ISO RGD:2843 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of HSPA5 mRNA more ... CTD PMID:17303341 , PMID:19564919 selenomethionine multiple interactions ISO RGD:2843 6480464 Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA], Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 protein] CTD PMID:29454614 serpentine asbestos increases expression ISO RGD:10742 6480464 Asbestos more ... CTD PMID:25324550 serpentine asbestos increases expression EXP 6480464 Asbestos more ... CTD PMID:25324550 silicon dioxide affects secretion EXP 6480464 Silicon Dioxide analog affects the secretion of HSPA5 protein CTD PMID:25895662 silicon dioxide increases expression ISO RGD:2843 6480464 Silicon Dioxide results in increased expression of HSPA5 protein CTD PMID:31028789 silicon dioxide multiple interactions ISO RGD:2843 6480464 Poly G inhibits the reaction [Silicon Dioxide results in increased expression of HSPA5 protein] CTD PMID:31028789 silicon dioxide multiple interactions EXP 6480464 [Silicon Dioxide analog co-treated with Silver] results in increased expression of HSPA5 mRNA CTD PMID:22245057 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of HSPA5 mRNA CTD PMID:22245057 silver atom multiple interactions EXP 6480464 [Silicon Dioxide analog co-treated with Silver] results in increased expression of HSPA5 mRNA CTD PMID:22245057 silver(0) multiple interactions EXP 6480464 [Silicon Dioxide analog co-treated with Silver] results in increased expression of HSPA5 mRNA CTD PMID:22245057 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of HSPA5 mRNA, Simvastatin results in increased expression of HSPA5 protein CTD PMID:18664198 , PMID:19253821 sirolimus multiple interactions ISO RGD:10742 6480464 [Sirolimus co-treated with HRAS protein] results in decreased expression of HSPA5 protein, PPARD protein affects the reaction [[Sirolimus co-treated with HRAS protein] results in decreased expression of HSPA5 protein] CTD PMID:24898257 sirolimus multiple interactions ISO RGD:2843 6480464 Sirolimus inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein] CTD PMID:29870746 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of HSPA5 mRNA CTD PMID:24356939 SKF-96365 hydrochloride multiple interactions ISO RGD:2843 6480464 1-2-3-4-methoxyphenylpropoxy-4-methoxyphenylethyl-1H-imidazole inhibits the reaction [Doxorubicin results in increased expression of HSPA5 protein] CTD PMID:28495616 sodium arsenate increases expression ISO RGD:10742 6480464 sodium arsenate results in increased expression of HSPA5 mRNA CTD PMID:30953684 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of HSPA5 protein CTD PMID:15899475 sodium arsenite multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein] CTD PMID:32506763 sodium arsenite increases expression ISO RGD:2843 6480464 sodium arsenite results in increased expression of HSPA5 protein CTD PMID:29459688 sodium arsenite affects localization ISO RGD:10742 6480464 sodium arsenite affects the localization of HSPA5 protein CTD PMID:21911445 sodium arsenite increases expression ISO RGD:10742 6480464 sodium arsenite results in increased expression of HSPA5 mRNA, sodium arsenite results in increased expression of HSPA5 protein CTD PMID:17451858 , PMID:21911445 sodium arsenite multiple interactions ISO RGD:10742 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein] CTD PMID:21911445 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of HSPA5 protein CTD PMID:21925251 , PMID:32506763 sodium fluoride affects expression ISO RGD:10742 6480464 Sodium Fluoride affects the expression of HSPA5 protein CTD PMID:25132241 sodium fluoride multiple interactions ISO RGD:2843 6480464 Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein] CTD PMID:30633982 sodium fluoride decreases expression ISO RGD:10742 6480464 Sodium Fluoride results in decreased expression of HSPA5 protein CTD PMID:27548804 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of HSPA5 mRNA, Sodium Fluoride results in increased expression of HSPA5 protein CTD PMID:24231001 sodium fluoride multiple interactions EXP 6480464 Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 mRNA], Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein] CTD PMID:24231001 sodium fluoride increases expression ISO RGD:10742 6480464 Sodium Fluoride results in increased expression of HSPA5 mRNA, Sodium Fluoride results in increased expression of HSPA5 protein CTD PMID:21626649 sodium fluoride increases expression ISO RGD:2843 6480464 Sodium Fluoride results in increased expression of HSPA5 mRNA, Sodium Fluoride results in increased expression of HSPA5 protein CTD PMID:23707774 , PMID:30633982 sodium fluoride affects expression ISO RGD:2843 6480464 Sodium Fluoride affects the expression of HSPA5 mRNA CTD PMID:25132241 sorafenib multiple interactions EXP 6480464 [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... CTD PMID:18787411 SR 144528 multiple interactions EXP 6480464 [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of HSPA5 mRNA] CTD PMID:31054322 streptozocin multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein] more ... CTD PMID:19634143 more ... streptozocin increases expression ISO RGD:2843 6480464 Streptozocin results in increased expression of HSPA5 protein CTD PMID:30980806 streptozocin multiple interactions ISO RGD:10742 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of HSPA5 protein, sulforaphane inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein] CTD PMID:24967692 , PMID:26522834 streptozocin increases expression ISO RGD:10742 6480464 Streptozocin results in increased expression of HSPA5 protein CTD PMID:24967692 streptozocin decreases expression ISO RGD:2843 6480464 Streptozocin results in decreased expression of HSPA5 protein CTD PMID:19634143 sulforaphane multiple interactions ISO RGD:10742 6480464 sulforaphane inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein] CTD PMID:24967692 sulfur dioxide multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased expression of HSPA5 mRNA CTD PMID:31268311 sulfur dioxide multiple interactions ISO RGD:2843 6480464 Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein] CTD PMID:30503585 sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of HSPA5 mRNA CTD PMID:31533062 T-2 toxin multiple interactions ISO RGD:10742 6480464 T-2 Toxin results in increased degradation of and results in decreased expression of HSPA5 protein CTD PMID:19336499 T-2 toxin increases expression ISO RGD:2843 6480464 T-2 Toxin results in increased expression of HSPA5 mRNA, T-2 Toxin results in increased expression of HSPA5 protein CTD PMID:29454614 T-2 toxin multiple interactions ISO RGD:2843 6480464 Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 mRNA], Selenomethionine inhibits the reaction [T-2 Toxin results in increased expression of HSPA5 protein] CTD PMID:29454614 T-2 toxin increases expression ISO RGD:10742 6480464 T-2 Toxin results in increased expression of HSPA5 protein CTD PMID:31170431 T-2 toxin affects expression ISO RGD:2843 6480464 T-2 Toxin affects the expression of HSPA5 protein CTD PMID:26141394 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of HSPA5 protein CTD PMID:31170431 tacrolimus hydrate increases expression ISO RGD:10742 6480464 Tacrolimus results in increased expression of HSPA5 mRNA CTD PMID:25270620 tamoxifen multiple interactions EXP 6480464 Tamoxifen promotes the reaction [Nelfinavir results in increased expression of HSPA5 protein] CTD PMID:20594311 tamoxifen multiple interactions ISO RGD:10742 6480464 Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of HSPA5 protein], Tamoxifen inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein] CTD PMID:23038002 tamoxifen increases expression ISO RGD:2843 6480464 Tamoxifen results in increased expression of HSPA5 mRNA CTD PMID:19400957 tamoxifen increases expression ISO RGD:10742 6480464 Tamoxifen results in increased expression of HSPA5 mRNA CTD PMID:19400957 tamoxifen affects expression ISO RGD:10742 6480464 Tamoxifen affects the expression of HSPA5 mRNA CTD PMID:17555576 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of HSPA5 protein CTD PMID:19812351 tanespimycin increases expression EXP 6480464 tanespimycin results in increased expression of HSPA5 protein CTD PMID:16357177 tauroursodeoxycholic acid multiple interactions EXP 6480464 ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] more ... CTD PMID:12198651 more ... tauroursodeoxycholic acid multiple interactions ISO RGD:10742 6480464 ursodoxicoltaurine inhibits the reaction [2 more ... CTD PMID:25160872 more ... tauroursodeoxycholic acid increases expression ISO RGD:10742 6480464 ursodoxicoltaurine results in increased expression of HSPA5 protein CTD PMID:25160872 tauroursodeoxycholic acid multiple interactions ISO RGD:2843 6480464 ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA] CTD PMID:20165829 telmisartan decreases expression ISO RGD:2843 6480464 telmisartan results in decreased expression of HSPA5 protein CTD PMID:19102871 TEMPO multiple interactions ISO RGD:2843 6480464 TEMPO inhibits the reaction [nickel sulfate results in increased expression of HSPA5 mRNA], TEMPO inhibits the reaction [nickel sulfate results in increased expression of HSPA5 protein] CTD PMID:28296042 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of HSPA5 mRNA CTD PMID:12766906 testosterone affects expression ISO RGD:10742 6480464 Testosterone affects the expression of HSPA5 mRNA CTD PMID:17003280 tetrachloromethane affects expression ISO RGD:2843 6480464 Carbon Tetrachloride affects the expression of HSPA5 mRNA CTD PMID:15963342 tetrachloromethane increases expression ISO RGD:2843 6480464 Carbon Tetrachloride results in increased expression of HSPA5 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:10742 6480464 1-trifluoromethoxyphenyl-3-1-propionylpiperidine-4-ylurea inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 mRNA], STF 083010 inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 protein] CTD PMID:25827057 , PMID:30538632 tetrachloromethane increases expression ISO RGD:10742 6480464 Carbon Tetrachloride results in increased expression of HSPA5 mRNA, Carbon Tetrachloride results in increased expression of HSPA5 protein CTD PMID:25827057 more ... tetrachloromethane multiple interactions ISO RGD:2843 6480464 [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA more ... CTD PMID:20097184 , PMID:31150632 thapsigargin multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] more ... CTD PMID:12198651 more ... thapsigargin increases expression ISO RGD:10742 6480464 Thapsigargin results in increased expression of HSPA5 mRNA, Thapsigargin results in increased expression of HSPA5 protein CTD PMID:14610226 more ... thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of HSPA5 mRNA, Thapsigargin results in increased expression of HSPA5 protein CTD PMID:12147617 more ... thapsigargin increases expression ISO RGD:2843 6480464 Thapsigargin results in increased expression of HSPA5 more ... CTD PMID:16236328 more ... thapsigargin multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] more ... CTD PMID:17915553 more ... thapsigargin multiple interactions ISO RGD:10742 6480464 [Thapsigargin co-treated with HRAS protein] results in increased expression of HSPA5 protein more ... CTD PMID:17475668 more ... thiostrepton increases expression EXP 6480464 Thiostrepton results in increased expression of HSPA5 mRNA CTD PMID:22321511 thymoquinone multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of HSPA5 protein] CTD PMID:29981725 thymoquinone increases expression EXP 6480464 thymoquinone results in increased expression of HSPA5 mRNA, thymoquinone results in increased expression of HSPA5 protein CTD PMID:29981725 Tiron multiple interactions ISO RGD:10742 6480464 1 more ... CTD PMID:23892647 titanium dioxide increases expression ISO RGD:10742 6480464 titanium dioxide results in increased expression of HSPA5 mRNA, titanium dioxide results in increased expression of HSPA5 protein CTD PMID:23557971 more ... titanium dioxide multiple interactions ISO RGD:10742 6480464 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 mRNA], 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 protein] CTD PMID:31298478 toluene increases expression EXP 6480464 Toluene results in increased expression of HSPA5 protein CTD PMID:12183065 toluene increases expression ISO RGD:2843 6480464 Toluene results in increased expression of HSPA5 mRNA CTD PMID:22967744 transplatin decreases expression EXP 6480464 transplatin results in decreased expression of HSPA5 mRNA CTD PMID:11099651 triadimefon decreases expression ISO RGD:2843 6480464 triadimefon results in decreased expression of HSPA5 mRNA CTD PMID:16643972 tributylstannane multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [tributyltin results in increased expression of HSPA5 protein] more ... CTD PMID:23743301 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of HSPA5 mRNA CTD PMID:27678064 tributylstannane increases expression EXP 6480464 tributyltin analog results in increased expression of HSPA5 protein, tributyltin results in increased expression of HSPA5 protein CTD PMID:23743301 , PMID:31634547 Tributyltin oxide increases expression ISO RGD:10742 6480464 bistri-n-butyltinoxide results in increased expression of HSPA5 mRNA CTD PMID:22434021 trichloroethene decreases expression ISO RGD:10742 6480464 Trichloroethylene results in decreased expression of HSPA5 mRNA CTD PMID:15363585 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of HSPA5 mRNA CTD PMID:24935251 trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of HSPA5 mRNA CTD PMID:28542535 triclocarban increases expression EXP 6480464 triclocarban results in increased expression of HSPA5 mRNA, triclocarban results in increased expression of HSPA5 protein CTD PMID:30592132 triphenylstannane increases expression EXP 6480464 triphenyltin analog results in increased expression of HSPA5 protein CTD PMID:31634547 Triptolide decreases expression ISO RGD:10742 6480464 triptolide results in decreased expression of HSPA5 protein CTD PMID:26990902 triptonide decreases expression ISO RGD:10742 6480464 triptonide results in decreased expression of HSPA5 mRNA CTD PMID:33045310 troglitazone affects response to substance EXP 6480464 HSPA5 protein affects the susceptibility to troglitazone CTD PMID:15525695 troglitazone decreases expression ISO RGD:2843 6480464 troglitazone results in decreased expression of HSPA5 mRNA CTD PMID:25596134 troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of HSPA5 mRNA, Troglitazone results in increased expression of HSPA5 protein CTD PMID:15525695 , PMID:19631733 tunicamycin multiple interactions EXP 6480464 Bortezomib inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] more ... CTD PMID:16357177 more ... tunicamycin increases expression ISO RGD:10742 6480464 Tunicamycin results in increased expression of HSPA5 mRNA, Tunicamycin results in increased expression of HSPA5 protein CTD PMID:15019097 more ... tunicamycin increases expression ISO RGD:2843 6480464 Tunicamycin results in increased expression of HSPA5 mRNA, Tunicamycin results in increased expression of HSPA5 protein CTD PMID:15049342 more ... tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of HSPA5 mRNA, Tunicamycin results in increased expression of HSPA5 protein CTD PMID:12147617 more ... tunicamycin multiple interactions ISO RGD:2843 6480464 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] more ... CTD PMID:18477628 more ... tunicamycin multiple interactions ISO RGD:10742 6480464 3-N-1spermine-7 more ... CTD PMID:20015086 more ... U-73122 multiple interactions EXP 6480464 1-6-3-methoxyestra-1 more ... CTD PMID:33421459 uranium atom increases expression EXP 6480464 Uranium results in increased expression of HSPA5 mRNA CTD PMID:14971665 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of HSPA5 mRNA CTD PMID:24312631 ursolic acid multiple interactions EXP 6480464 1 more ... CTD PMID:24802810 ursolic acid increases expression EXP 6480464 ursolic acid results in increased expression of HSPA5 protein CTD PMID:24802810 usnic acid multiple interactions EXP 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSPA5 mRNA CTD PMID:22777745 valproic acid increases expression ISO RGD:2843 6480464 Valproic Acid results in increased expression of HSPA5 protein CTD PMID:16236328 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HSPA5 mRNA CTD PMID:23179753 more ... valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of HSPA5 mRNA CTD PMID:25979313 valproic acid affects expression ISO RGD:10742 6480464 Valproic Acid affects the expression of HSPA5 mRNA CTD PMID:17292431 vemurafenib multiple interactions EXP 6480464 [KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of HSPA5 protein CTD PMID:27222248 vinclozolin decreases expression ISO RGD:2843 6480464 vinclozolin results in decreased expression of HSPA5 mRNA CTD PMID:15686871 , PMID:23034163 vincristine increases expression ISO RGD:2843 6480464 Vincristine results in increased expression of HSPA5 mRNA CTD PMID:33038355 vincristine multiple interactions ISO RGD:2843 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of HSPA5 mRNA] CTD PMID:33038355 vitamin E multiple interactions ISO RGD:10742 6480464 Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein] CTD PMID:18068688 vitexin multiple interactions ISO RGD:10742 6480464 vitexin inhibits the reaction [APP protein modified form results in decreased expression of HSPA5 mRNA] CTD PMID:29545167 vorinostat multiple interactions EXP 6480464 [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... CTD PMID:18787411 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] CTD PMID:19428936 xylitol increases expression EXP 6480464 Xylitol results in increased expression of HSPA5 protein CTD PMID:32275922 xylitol multiple interactions EXP 6480464 ursodoxicoltaurine inhibits the reaction [Xylitol results in increased expression of HSPA5 protein] CTD PMID:32275922 Z-Val-Phe-H multiple interactions ISO RGD:10742 6480464 calpain inhibitor III inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein] CTD PMID:19336499 zearalenone increases expression ISO RGD:10742 6480464 Zearalenone results in increased expression of HSPA5 protein CTD PMID:30394307 , PMID:31982503 zearalenone multiple interactions ISO RGD:10742 6480464 2-aminoethyl diphenylborinate inhibits the reaction [Zearalenone results in increased expression of HSPA5 protein], 4-phenylbutylamine promotes the reaction [Zearalenone results in increased expression of HSPA5 protein] CTD PMID:30394307 , PMID:31982503 zinc atom multiple interactions ISO RGD:2843 6480464 Zinc inhibits the reaction [lead acetate binds to HSPA5 protein] CTD PMID:10702365 zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPA5 mRNA CTD PMID:18593933 zinc oxide increases expression ISO RGD:10742 6480464 Zinc Oxide analog results in increased expression of HSPA5 mRNA CTD PMID:25680694 zinc pyrithione increases expression EXP 6480464 pyrithione zinc results in increased expression of HSPA5 mRNA CTD PMID:21424779 zinc(0) multiple interactions ISO RGD:2843 6480464 Zinc inhibits the reaction [lead acetate binds to HSPA5 protein] CTD PMID:10702365 zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPA5 mRNA CTD PMID:18593933 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of HSPA5 mRNA CTD PMID:25596134
